"path_id"	"full_path_length.x"	"testable_path_length.x"	"drug_targeted_genes"	"proportion_drug_targeted"	"full_path_length.y"	"testable_path_length.y"	"aberrational_genes"	"proportion_aberrational"	"proportion_of_cohort_w_aberrational_gene_in_path"	"Num_patient_with_aberrational_gene_.s._in_path"	"count_of_aberrational_genes_in_path_cross_cohort"	"max_in_one_gene"	"min_in_one_gene"	"hyperg_p_value"	"hyperg_p_w_FDR"
"188"	"Signaling by FGFR"	162	162	47	0.290123456790123	162	162	152	0.938271604938272	0.753378378378378	223	1122	82	0	0.00167485312765603	0.0686646455174402
"347"	"Signaling by FGFR mutants"	45	45	9	0.2	45	45	44	0.977777777777778	0.625	185	480	82	0	0.0019930276799156	0.0814536385073593
"483"	"G-protein mediated events"	44	44	6	0.136363636363636	44	44	43	0.977272727272727	0.429054054054054	127	243	31	0	0.00228934156056315	0.0932723023074214
"631"	"Neuronal System"	280	280	24	0.0857142857142857	280	280	258	0.921428571428571	0.760135135135135	225	1739	86	0	0.00256529712177689	0.104190695960871
"475"	"PLC beta mediated events"	43	43	6	0.13953488372093	43	43	42	0.976744186046512	0.415540540540541	123	237	31	0	0.00262965845618424	0.10614547184971
"740"	"Voltage gated Potassium channels"	43	43	2	0.0465116279069767	43	43	42	0.976744186046512	0.442567567567568	131	269	42	0	0.00262965845618424	0.10614547184971
"734"	"Neurotransmitter Release Cycle"	42	42	2	0.0476190476190476	42	42	41	0.976190476190476	0.523648648648649	155	278	86	0	0.00302050522536423	0.121546754570814
"205"	"DAP12 signaling"	164	164	46	0.280487804878049	164	164	153	0.932926829268293	0.756756756756757	224	1130	82	0	0.00349874838770603	0.140359640784941
"269"	"Signaling by PDGF"	184	184	46	0.25	184	184	171	0.929347826086957	0.760135135135135	225	1256	82	0	0.00378200307968446	0.151211118157082
"182"	"Signaling by ERBB2"	163	163	48	0.294478527607362	163	163	152	0.932515337423313	0.763513513513513	226	1132	82	0	0.00379236763708346	0.151211118157082
"193"	"Downstream signal transduction"	161	161	46	0.285714285714286	161	161	150	0.93167701863354	0.75	222	1141	82	0	0.0044508213386506	0.176925894661255
"858"	"GABA receptor activation"	55	55	1	0.0181818181818182	55	55	53	0.963636363636364	0.425675675675676	126	263	31	0	0.00457473377269535	0.181300508522276
"181"	"Downstream signaling of activated FGFR"	149	149	44	0.295302013422819	149	149	139	0.932885906040268	0.743243243243243	220	1071	82	0	0.00498146739934857	0.196823266668169
"291"	"Signaling by Insulin receptor"	116	116	26	0.224137931034483	116	116	109	0.939655172413793	0.695945945945946	206	956	82	0	0.00508257039076143	0.200213083911994
"333"	"Phospholipase C-mediated cascade"	54	54	11	0.203703703703704	54	54	52	0.962962962962963	0.554054054054054	164	536	82	0	0.00517005446449015	0.203047675269454
"565"	"Cyclin D associated events in G1"	38	38	4	0.105263157894737	38	38	37	0.973684210526316	0.665540540540541	197	473	83	0	0.00525672859747117	0.20460837894054
"566"	"G1 Phase"	38	38	4	0.105263157894737	38	38	37	0.973684210526316	0.665540540540541	197	473	83	0	0.00525672859747117	0.20460837894054
"569"	"Transport of vitamins, nucleosides, and related molecules"	38	38	4	0.105263157894737	38	38	37	0.973684210526316	0.39527027027027	117	275	51	0	0.00525672859747117	0.20460837894054
"765"	"SLC-mediated transmembrane transport"	259	259	10	0.0386100386100386	259	259	238	0.918918918918919	0.716216216216216	212	1345	56	0	0.0053286628733944	0.206792831918712
"628"	"Opioid Signalling"	80	80	7	0.0875	80	80	76	0.95	0.581081081081081	172	491	59	0	0.00549187320514311	0.212496087573161
"139"	"Cyclin A:Cdk2-associated events at S phase entry"	66	66	22	0.333333333333333	66	66	63	0.954545454545455	0.527027027027027	156	329	55	0	0.0063181815718687	0.243747147005637
"247"	"Mitotic G1-G1/S phases"	135	135	36	0.266666666666667	135	135	126	0.933333333333333	0.810810810810811	240	966	83	0	0.00654213051376606	0.251644488932162
"813"	"Beta defensins"	36	36	1	0.0277777777777778	36	36	35	0.972222222222222	0.263513513513513	78	303	41	0	0.0069339795833101	0.265934888130434
"121"	"Cyclin E associated events during G1/S transition"	65	65	23	0.353846153846154	65	65	62	0.953846153846154	0.523648648648649	155	326	55	0	0.00706086458222965	0.270009418257978
"764"	"Regulation of insulin secretion"	77	77	3	0.038961038961039	77	77	73	0.948051948051948	0.567567567567568	168	480	59	0	0.00749784059377523	0.285883585114199
"272"	"Hedgehog 'off' state"	99	99	24	0.242424242424242	99	99	93	0.939393939393939	0.591216216216216	175	486	55	0	0.00857368948576998	0.325009302989543
"849"	"Potassium Channels"	99	99	2	0.0202020202020202	99	99	93	0.939393939393939	0.587837837837838	174	644	60	0	0.00857368948576998	0.325009302989543
"278"	"PLCG1 events in ERBB2 signaling"	34	34	8	0.235294117647059	34	34	33	0.970588235294118	0.445945945945946	132	219	32	0	0.0091456715815923	0.345689859383584
"869"	"Mitochondrial translation elongation"	86	86	1	0.0116279069767442	86	86	81	0.941860465116279	0.584459459459459	173	567	58	0	0.00995918888232783	0.375354503704239
"591"	"Signal Transduction"	2062	2062	209	0.101357904946654	2062	2062	1826	0.885548011639185	0.939189189189189	278	10774	82	0	0.0102220941030848	0.384156129916001
"312"	"E2F mediated regulation of DNA replication"	33	33	7	0.212121212121212	33	33	32	0.96969696969697	0.402027027027027	119	189	18	0	0.0105031458096945	0.391344662534572
"313"	"EGFR interacts with phospholipase C-gamma"	33	33	7	0.212121212121212	33	33	32	0.96969696969697	0.435810810810811	129	211	32	0	0.0105031458096945	0.391344662534572
"811"	"Sialic acid metabolism"	33	33	1	0.0303030303030303	33	33	32	0.96969696969697	0.442567567567568	131	211	55	0	0.0105031458096945	0.391344662534572
"681"	"G alpha (q) signalling events"	189	189	12	0.0634920634920635	189	189	174	0.920634920634921	0.668918918918919	198	1202	60	0	0.0112948204996399	0.419646694621896
"613"	"Signal amplification"	32	32	3	0.09375	32	32	31	0.96875	0.35472972972973	105	288	59	0	0.0120618716953103	0.445613746052443
"686"	"TRAF6 mediated IRF7 activation"	32	32	2	0.0625	32	32	31	0.96875	0.35472972972973	105	440	43	0	0.0120618716953103	0.445613746052443
"479"	"Gastrin-CREB signalling pathway via PKC and MAPK"	217	217	30	0.138248847926267	217	217	199	0.91705069124424	0.736486486486487	218	1362	60	0	0.0121915475991228	0.448080829715783
"112"	"G1/S DNA Damage Checkpoints"	60	60	22	0.366666666666667	60	60	57	0.95	0.489864864864865	145	292	55	0	0.012231435884864	0.448080829715783
"596"	"HDACs deacetylate histones"	60	60	6	0.1	60	60	57	0.95	0.402027027027027	119	281	60	0	0.012231435884864	0.448080829715783
"632"	"Mitotic Prophase"	106	106	9	0.0849056603773585	106	106	99	0.933962264150943	0.537162162162162	159	491	43	0	0.0122797238062186	0.448593223696541
"213"	"Removal of licensing factors from origins"	72	72	20	0.277777777777778	72	72	68	0.944444444444444	0.523648648648649	155	346	55	0	0.0124867658464789	0.454886089334074
"752"	"Defensins"	46	46	2	0.0434782608695652	46	46	44	0.956521739130435	0.331081081081081	98	391	41	0	0.0136028211383215	0.494166867311935
"152"	"CDT1 association with the CDC6:ORC:origin complex"	58	58	19	0.327586206896552	58	58	55	0.948275862068966	0.445945945945946	132	274	55	0	0.0151903064299727	0.549851721348114
"196"	"Orc1 removal from chromatin"	70	70	20	0.285714285714286	70	70	66	0.942857142857143	0.52027027027027	154	342	55	0	0.0152617760763121	0.549851721348114
"199"	"Switching of origins to a post-replicative state"	70	70	20	0.285714285714286	70	70	66	0.942857142857143	0.52027027027027	154	342	55	0	0.0152617760763121	0.549851721348114
"348"	"Signaling by FGFR1 mutants"	30	30	6	0.2	30	30	29	0.966666666666667	0.577702702702703	171	326	82	0	0.0159066924919797	0.568389356411122
"668"	"Amine compound SLC transporters"	30	30	2	0.0666666666666667	30	30	29	0.966666666666667	0.263513513513513	78	186	26	0	0.0159066924919797	0.568389356411122
"787"	"Adherens junctions interactions"	30	30	1	0.0333333333333333	30	30	29	0.966666666666667	0.310810810810811	92	198	17	0	0.0159066924919797	0.568389356411122
"201"	"IGF1R signaling cascade"	92	92	26	0.282608695652174	92	92	86	0.934782608695652	0.672297297297297	199	798	82	0	0.0161229365731363	0.572985278079177
"203"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	92	92	26	0.282608695652174	92	92	86	0.934782608695652	0.672297297297297	199	798	82	0	0.0161229365731363	0.572985278079177
"93"	"Signaling by VEGF"	113	113	44	0.389380530973451	113	113	105	0.929203539823009	0.658783783783784	195	634	60	0	0.0166351985075726	0.589588166505355
"130"	"p53-Dependent G1 DNA Damage Response"	57	57	20	0.350877192982456	57	57	54	0.947368421052632	0.483108108108108	143	280	55	0	0.0169160001693827	0.596308373719012
"131"	"p53-Dependent G1/S DNA damage checkpoint"	57	57	20	0.350877192982456	57	57	54	0.947368421052632	0.483108108108108	143	280	55	0	0.0169160001693827	0.596308373719012
"610"	"Antigen processing: Ubiquitination & Proteasome degradation"	211	211	20	0.0947867298578199	211	211	193	0.914691943127962	0.695945945945946	206	977	55	0	0.0176966308066141	0.622149544503888
"561"	"Transmission across Chemical Synapses"	201	201	22	0.109452736318408	201	201	184	0.915422885572139	0.739864864864865	219	1188	86	0	0.0182230986732296	0.638940668435972
"119"	"SCF(Skp2)-mediated degradation of p27/p21"	56	56	20	0.357142857142857	56	56	53	0.946428571428571	0.472972972972973	140	270	55	0	0.018828326735298	0.658396116842136
"185"	"IRS-related events triggered by IGF1R"	89	89	26	0.292134831460674	89	89	83	0.932584269662921	0.672297297297297	199	785	82	0	0.020977462446008	0.727710663478185
"255"	"DAP12 interactions"	179	179	46	0.256983240223464	179	179	164	0.916201117318436	0.756756756756757	224	1168	82	0	0.0218050221790477	0.754417700936025
"730"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	42	42	2	0.0476190476190476	42	42	40	0.952380952380952	0.493243243243243	146	286	59	0	0.0218730653819811	0.754775123624782
"180"	"IRS-related events"	88	88	26	0.295454545454545	88	88	82	0.931818181818182	0.668918918918919	198	785	82	0	0.0228767908199725	0.785726508760043
"216"	"G1/S Transition"	109	109	30	0.275229357798165	109	109	101	0.926605504587156	0.682432432432432	202	587	55	0	0.0228901819304448	0.785726508760043
"127"	"AUF1 (hnRNP D0) destabilizes mRNA"	54	54	19	0.351851851851852	54	54	51	0.944444444444444	0.459459459459459	136	318	55	0	0.0232896147746076	0.795262799955641
"663"	"Protein folding"	54	54	4	0.0740740740740741	54	54	51	0.944444444444444	0.472972972972973	140	266	25	0	0.0232896147746076	0.795262799955641
"809"	"Stimuli-sensing channels"	98	98	3	0.0306122448979592	98	98	91	0.928571428571429	0.64527027027027	191	614	85	0	0.0240477039863521	0.801221230366137
"724"	"Pre-NOTCH Transcription and Translation"	41	41	2	0.0487804878048781	41	41	39	0.951219512195122	0.557432432432432	165	296	80	0	0.0246047978033519	0.801221230366137
"570"	"Defective AMN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"571"	"Defective BTD causes biotidinase deficiency"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"572"	"Defective CD320 causes methylmalonic aciduria"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"573"	"Defective CUBN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"574"	"Defective GIF causes intrinsic factor deficiency"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"575"	"Defective HLCS causes multiple carboxylase deficiency"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"576"	"Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"577"	"Defective MMAA causes methylmalonic aciduria type cblA"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"578"	"Defective MMAB causes methylmalonic aciduria type cblB"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"579"	"Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"580"	"Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"581"	"Defective MTR causes methylmalonic aciduria and homocystinuria type cblG"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"582"	"Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"583"	"Defective MUT causes methylmalonic aciduria mut type"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"584"	"Defective TCN2 causes hereditary megaloblastic anemia"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"585"	"Defects in biotin (Btn) metabolism"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"586"	"Defects in cobalamin (B12) metabolism"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"587"	"Defects in vitamin and cofactor metabolism"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"588"	"Metabolism of vitamins and cofactors"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"589"	"Metabolism of water-soluble vitamins and cofactors"	87	87	9	0.103448275862069	87	87	81	0.931034482758621	0.597972972972973	177	492	60	0	0.0249344458578333	0.801221230366137
"314"	"Cell Cycle Checkpoints"	118	118	25	0.211864406779661	118	118	109	0.923728813559322	0.631756756756757	187	622	55	0	0.0251169494791611	0.805107487782285
"870"	"Mitochondrial translation initiation"	86	86	1	0.0116279069767442	86	86	80	0.930232558139535	0.581081081081081	172	525	58	0	0.0271620381332701	0.866414345992202
"871"	"Mitochondrial translation termination"	86	86	1	0.0116279069767442	86	86	80	0.930232558139535	0.581081081081081	172	528	58	0	0.0271620381332701	0.866414345992202
"176"	"APC/C:Cdc20 mediated degradation of Securin"	64	64	19	0.296875	64	64	60	0.9375	0.442567567567568	131	274	55	0	0.0275145012376806	0.873396737710644
"177"	"ER-Phagosome pathway"	64	64	19	0.296875	64	64	60	0.9375	0.47972972972973	142	315	55	0	0.0275145012376806	0.873396737710644
"818"	"PRC2 methylates histones and DNA"	40	40	1	0.025	40	40	38	0.95	0.243243243243243	72	149	14	0	0.0276650316070057	0.873932653176899
"248"	"Regulation of DNA replication"	75	75	20	0.266666666666667	75	75	70	0.933333333333333	0.547297297297297	162	363	55	0	0.0277501966377094	0.874510654388429
"73"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	52	52	21	0.403846153846154	52	52	49	0.942307692307692	0.435810810810811	129	246	55	0	0.0287450269157592	0.897213569965404
"74"	"p53-Independent DNA Damage Response"	52	52	21	0.403846153846154	52	52	49	0.942307692307692	0.435810810810811	129	246	55	0	0.0287450269157592	0.897213569965404
"75"	"p53-Independent G1/S DNA damage checkpoint"	52	52	21	0.403846153846154	52	52	49	0.942307692307692	0.435810810810811	129	246	55	0	0.0287450269157592	0.897213569965404
"114"	"Stabilization of p53"	52	52	19	0.365384615384615	52	52	49	0.942307692307692	0.449324324324324	133	256	55	0	0.0287450269157592	0.897213569965404
"359"	"Signaling by Hedgehog"	136	136	26	0.191176470588235	136	136	125	0.919117647058823	0.658783783783784	195	669	55	0	0.0288162492391584	0.897295104306072
"762"	"G alpha (s) signalling events"	126	126	5	0.0396825396825397	126	126	116	0.920634920634921	0.652027027027027	193	687	59	0	0.0291016396844811	0.904029287246068
"184"	"IRS-mediated signalling"	85	85	25	0.294117647058824	85	85	79	0.929411764705882	0.665540540540541	197	772	82	0	0.0295718450862449	0.914292572939386
"224"	"Hedgehog 'on' state"	85	85	23	0.270588235294118	85	85	79	0.929411764705882	0.550675675675676	163	404	55	0	0.0295718450862449	0.914292572939386
"166"	"Asymmetric localization of PCP proteins"	63	63	19	0.301587301587302	63	63	59	0.936507936507937	0.516891891891892	153	345	55	0	0.0302939775613488	0.93441021950693
"85"	"VEGFA-VEGFR2 Pathway"	105	105	42	0.4	105	105	97	0.923809523809524	0.652027027027027	193	594	60	0	0.0312402830771461	0.956828763451432
"413"	"Regulation of IFNA signaling"	25	25	4	0.16	25	25	24	0.96	0.206081081081081	61	366	26	0	0.0317573719937777	0.963639121155151
"644"	"ADP signalling through P2Y purinoceptor 1"	25	25	2	0.08	25	25	24	0.96	0.337837837837838	100	216	59	0	0.0317573719937777	0.963639121155151
"647"	"Nitric oxide stimulates guanylate cyclase"	25	25	2	0.08	25	25	24	0.96	0.391891891891892	116	230	60	0	0.0317573719937777	0.963639121155151
"109"	"Autodegradation of the E3 ubiquitin ligase COP1"	51	51	19	0.372549019607843	51	51	48	0.941176470588235	0.429054054054054	127	240	55	0	0.0319071328445077	0.965942268050104
"134"	"Signaling by SCF-KIT"	144	144	49	0.340277777777778	144	144	132	0.916666666666667	0.773648648648649	229	1046	82	0	0.0324167082977025	0.979102486452165
"167"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	73	73	22	0.301369863013699	73	73	68	0.931506849315068	0.449324324324324	133	289	55	0	0.0331945641855461	1
"642"	"Class I MHC mediated antigen processing & presentation"	255	255	21	0.0823529411764706	255	255	231	0.905882352941176	0.736486486486487	218	1172	55	0	0.0338177645966422	1
"771"	"Peptide hormone metabolism"	83	83	3	0.036144578313253	83	83	77	0.927710843373494	0.550675675675676	163	534	49	0	0.0349906415083165	1
"66"	"Ubiquitin-dependent degradation of Cyclin D"	50	50	21	0.42	50	50	47	0.94	0.537162162162162	159	310	80	0	0.0353958181122058	1
"67"	"Ubiquitin-dependent degradation of Cyclin D1"	50	50	21	0.42	50	50	47	0.94	0.537162162162162	159	310	80	0	0.0353958181122058	1
"78"	"CDK-mediated phosphorylation and removal of Cdc6"	50	50	20	0.4	50	50	47	0.94	0.418918918918919	124	236	55	0	0.0353958181122058	1
"82"	"Regulation of Apoptosis"	50	50	20	0.4	50	50	47	0.94	0.422297297297297	125	281	55	0	0.0353958181122058	1
"99"	"Regulation of ornithine decarboxylase (ODC)"	50	50	19	0.38	50	50	47	0.94	0.435810810810811	129	248	55	0	0.0353958181122058	1
"186"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	72	72	21	0.291666666666667	72	72	67	0.930555555555556	0.445945945945946	132	287	55	0	0.0362719425134002	1
"499"	"DARPP-32 events"	24	24	3	0.125	24	24	23	0.958333333333333	0.287162162162162	85	130	23	0	0.0364646533972328	1
"183"	"Downstream signaling events of B Cell Receptor (BCR)"	170	170	50	0.294117647058824	170	170	155	0.911764705882353	0.75	222	1141	82	0	0.0380905426034428	1
"202"	"Insulin receptor signalling cascade"	92	92	26	0.282608695652174	92	92	85	0.923913043478261	0.668918918918919	198	798	82	0	0.0389332495922651	1
"874"	"Mitochondrial translation"	92	92	1	0.0108695652173913	92	92	85	0.923913043478261	0.591216216216216	175	580	58	0	0.0389332495922651	1
"72"	"Regulation of activated PAK-2p34 by proteasome mediated degradation"	49	49	20	0.408163265306122	49	49	46	0.938775510204082	0.418918918918919	124	279	55	0	0.0392415942548661	1
"157"	"Autodegradation of Cdh1 by Cdh1:APC/C"	60	60	19	0.316666666666667	60	60	56	0.933333333333333	0.429054054054054	127	259	55	0	0.0402834661101575	1
"191"	"NGF signalling via TRKA from the plasma membrane"	206	206	59	0.286407766990291	206	206	187	0.907766990291262	0.787162162162162	233	1368	82	0	0.0405404424818256	1
"171"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	70	70	21	0.3	70	70	65	0.928571428571429	0.445945945945946	132	285	55	0	0.0432270161712609	1
"287"	"NCAM signaling for neurite out-growth"	70	70	16	0.228571428571429	70	70	65	0.928571428571429	0.560810810810811	166	357	34	0	0.0432270161712609	1
"535"	"Loss of Function of SMAD2/3 in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"536"	"Loss of Function of SMAD4 in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"537"	"Loss of Function of TGFBR1 in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"538"	"Loss of Function of TGFBR2 in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"540"	"SMAD2/3 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"541"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"542"	"SMAD4 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"543"	"Signaling by TGF-beta Receptor Complex"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"544"	"Signaling by TGF-beta Receptor Complex in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"545"	"TGFBR1 KD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"546"	"TGFBR1 LBD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"547"	"TGFBR2 Kinase Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"548"	"TGFBR2 MSI Frameshift Mutants in Cancer"	70	70	8	0.114285714285714	70	70	65	0.928571428571429	0.685810810810811	203	550	79	0	0.0432270161712609	1
"636"	"Chaperonin-mediated protein folding"	48	48	4	0.0833333333333333	48	48	45	0.9375	0.442567567567568	131	239	25	0	0.0434773241844946	1
"634"	"ABC-family proteins mediated transport"	36	36	3	0.0833333333333333	36	36	34	0.944444444444444	0.368243243243243	109	177	60	0	0.0439962786805549	1
"189"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	69	69	20	0.289855072463768	69	69	64	0.927536231884058	0.445945945945946	132	282	55	0	0.0471436545969872	1
"51"	"CTLA4 inhibitory signaling"	22	22	10	0.454545454545455	22	22	21	0.954545454545455	0.327702702702703	97	141	17	0	0.0480730609478828	1
"219"	"Cyclin A/B1 associated events during G2/M transition"	22	22	6	0.272727272727273	22	22	21	0.954545454545455	0.168918918918919	50	72	15	0	0.0480730609478828	1
"742"	"ADP signalling through P2Y purinoceptor 12"	22	22	1	0.0454545454545455	22	22	21	0.954545454545455	0.337837837837838	100	217	59	0	0.0480730609478828	1
"133"	"Hh ligand biogenesis disease"	58	58	20	0.344827586206897	58	58	54	0.931034482758621	0.476351351351351	141	278	55	0	0.048553718725233	1
"860"	"DNA Damage/Telomere Stress Induced Senescence"	58	58	1	0.0172413793103448	58	58	54	0.931034482758621	0.277027027027027	82	214	16	0	0.048553718725233	1
"624"	"RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"	79	79	7	0.0886075949367089	79	79	73	0.924050632911392	0.641891891891892	190	710	85	0	0.0486322088366306	1
"336"	"Bile acid and bile salt metabolism"	35	35	7	0.2	35	35	33	0.942857142857143	0.27027027027027	80	143	15	0	0.0493399170424593	1
"298"	"PI3K Cascade"	68	68	15	0.220588235294118	68	68	63	0.926470588235294	0.618243243243243	183	692	82	0	0.0513806563145431	1
"778"	"Pre-NOTCH Expression and Processing"	57	57	2	0.0350877192982456	57	57	53	0.929824561403509	0.587837837837838	174	377	80	0	0.0532502049217725	1
"43"	"Signal transduction by L1"	21	21	10	0.476190476190476	21	21	20	0.952380952380952	0.358108108108108	106	151	32	0	0.0551955331643615	1
"725"	"APC/C:Cdc20 mediated degradation of Cyclin B"	21	21	1	0.0476190476190476	21	21	20	0.952380952380952	0.141891891891892	42	58	11	0	0.0551955331643615	1
"733"	"Mitochondrial tRNA aminoacylation"	21	21	1	0.0476190476190476	21	21	20	0.952380952380952	0.246621621621622	73	97	16	0	0.0551955331643615	1
"200"	"Assembly of the pre-replicative complex"	67	67	19	0.283582089552239	67	67	62	0.925373134328358	0.516891891891892	153	343	55	0	0.0559599877291123	1
"864"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	67	67	1	0.0149253731343284	67	67	62	0.925373134328358	0.503378378378378	149	378	56	0	0.0559599877291123	1
"252"	"Signaling by EGFR in Cancer"	181	181	47	0.259668508287293	181	181	164	0.906077348066298	0.766891891891892	227	1239	82	0	0.0584027352635025	1
"253"	"Signaling by EGFRvIII in Cancer"	181	181	47	0.259668508287293	181	181	164	0.906077348066298	0.766891891891892	227	1239	82	0	0.0584027352635025	1
"254"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	181	181	47	0.259668508287293	181	181	164	0.906077348066298	0.766891891891892	227	1239	82	0	0.0584027352635025	1
"674"	"RMTs methylate histone arginines"	45	45	3	0.0666666666666667	45	45	42	0.933333333333333	0.527027027027027	156	331	80	0	0.0588901371328656	1
"132"	"Activation of NF-kappaB in B cells"	66	66	23	0.348484848484849	66	66	61	0.924242424242424	0.503378378378378	149	316	55	0	0.0609045935847154	1
"187"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	86	86	25	0.290697674418605	86	86	79	0.918604651162791	0.537162162162162	159	491	55	0	0.061702604459241	1
"517"	"Metabolism of steroid hormones and vitamin D"	33	33	4	0.121212121212121	33	33	31	0.939393939393939	0.412162162162162	122	219	33	0	0.0619411000350171	1
"519"	"Steroid hormones"	33	33	4	0.121212121212121	33	33	31	0.939393939393939	0.412162162162162	122	219	33	0	0.0619411000350171	1
"691"	"Glucagon signaling in metabolic regulation"	33	33	2	0.0606060606060606	33	33	31	0.939393939393939	0.449324324324324	133	242	59	0	0.0619411000350171	1
"692"	"Negative regulators of RIG-I/MDA5 signaling"	33	33	2	0.0606060606060606	33	33	31	0.939393939393939	0.293918918918919	87	124	13	0	0.0619411000350171	1
"304"	"S Phase"	124	124	27	0.217741935483871	124	124	113	0.911290322580645	0.706081081081081	209	806	80	0	0.0638257050700581	1
"256"	"Signaling by EGFR"	179	179	46	0.256983240223464	179	179	162	0.905027932960894	0.766891891891892	227	1227	82	0	0.0650247624009788	1
"257"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	179	179	46	0.256983240223464	179	179	162	0.905027932960894	0.766891891891892	227	1227	82	0	0.0650247624009788	1
"779"	"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription"	114	114	4	0.0350877192982456	114	114	104	0.912280701754386	0.577702702702703	171	481	55	0	0.0661295328164457	1
"414"	"Senescence-Associated Secretory Phenotype (SASP)"	75	75	12	0.16	75	75	69	0.92	0.537162162162162	159	403	83	0	0.0668920218937754	1
"19"	"VEGFR2 mediated cell proliferation"	32	32	17	0.53125	32	32	30	0.9375	0.293918918918919	87	122	18	0	0.0693348025132965	1
"45"	"CD28 co-stimulation"	32	32	15	0.46875	32	32	30	0.9375	0.445945945945946	132	266	60	0	0.0693348025132965	1
"361"	"Activation of Matrix Metalloproteinases"	32	32	6	0.1875	32	32	30	0.9375	0.266891891891892	79	229	24	0	0.0693348025132965	1
"504"	"Regulation of beta-cell development"	32	32	4	0.125	32	32	30	0.9375	0.452702702702703	134	258	56	0	0.0693348025132965	1
"511"	"Thrombin signalling through proteinase activated receptors (PARs)"	32	32	4	0.125	32	32	30	0.9375	0.39527027027027	117	212	59	0	0.0693348025132965	1
"684"	"Sphingolipid de novo biosynthesis"	32	32	2	0.0625	32	32	30	0.9375	0.391891891891892	116	175	44	0	0.0693348025132965	1
"685"	"TGF-beta receptor signaling activates SMADs"	32	32	2	0.0625	32	32	30	0.9375	0.300675675675676	89	144	23	0	0.0693348025132965	1
"805"	"DNA methylation"	32	32	1	0.03125	32	32	30	0.9375	0.128378378378378	38	98	10	0	0.0693348025132965	1
"110"	"degradation of AXIN"	54	54	20	0.37037037037037	54	54	50	0.925925925925926	0.449324324324324	133	249	55	0	0.0699387404391314	1
"739"	"Vasopressin regulates renal water homeostasis via Aquaporins"	43	43	2	0.0465116279069767	43	43	40	0.930232558139535	0.506756756756757	150	299	59	0	0.0718314803285672	1
"826"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	43	43	1	0.0232558139534884	43	43	40	0.930232558139535	0.412162162162162	122	244	26	0	0.0718314803285672	1
"316"	"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"	19	19	4	0.210526315789474	19	19	18	0.947368421052632	0.391891891891892	116	148	60	0	0.0727583575841748	1
"567"	"Na+/Cl- dependent neurotransmitter transporters"	19	19	2	0.105263157894737	19	19	18	0.947368421052632	0.189189189189189	56	139	26	0	0.0727583575841748	1
"709"	"Glucuronidation"	19	19	1	0.0526315789473684	19	19	18	0.947368421052632	0.0405405405405405	12	46	4	0	0.0727583575841748	1
"711"	"Synthesis of PC"	19	19	1	0.0526315789473684	19	19	18	0.947368421052632	0.385135135135135	114	201	51	0	0.0727583575841748	1
"204"	"PI3K/AKT activation"	103	103	29	0.281553398058252	103	103	94	0.912621359223301	0.695945945945946	206	824	82	0	0.0730101163887995	1
"375"	"Platelet activation, signaling and aggregation"	221	221	39	0.176470588235294	221	221	199	0.900452488687783	0.702702702702703	208	1525	60	0	0.074541238962827	1
"822"	"Triglyceride Biosynthesis"	42	42	1	0.0238095238095238	42	42	39	0.928571428571429	0.456081081081081	135	234	31	0	0.0792394462307694	1
"823"	"tRNA Aminoacylation"	42	42	1	0.0238095238095238	42	42	39	0.928571428571429	0.35472972972973	105	181	16	0	0.0792394462307694	1
"294"	"Post-chaperonin tubulin folding pathway"	18	18	4	0.222222222222222	18	18	17	0.944444444444444	0.182432432432432	54	67	12	0	0.0835333096498754	1
"296"	"Tie2 Signaling"	18	18	4	0.222222222222222	18	18	17	0.944444444444444	0.412162162162162	122	188	60	0	0.0835333096498754	1
"388"	"Activation of SMO"	18	18	3	0.166666666666667	18	18	17	0.944444444444444	0.246621621621622	73	104	24	0	0.0835333096498754	1
"552"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	18	18	2	0.111111111111111	18	18	17	0.944444444444444	0.202702702702703	60	78	15	0	0.0835333096498754	1
"554"	"Norepinephrine Neurotransmitter Release Cycle"	18	18	2	0.111111111111111	18	18	17	0.944444444444444	0.435810810810811	129	161	86	0	0.0835333096498754	1
"558"	"Synthesis of PIPs at the Golgi membrane"	18	18	2	0.111111111111111	18	18	17	0.944444444444444	0.216216216216216	64	87	14	0	0.0835333096498754	1
"559"	"cGMP effects"	18	18	2	0.111111111111111	18	18	17	0.944444444444444	0.351351351351351	104	201	60	0	0.0835333096498754	1
"855"	"Synthesis of substrates in N-glycan biosythesis"	52	52	1	0.0192307692307692	52	52	48	0.923076923076923	0.466216216216216	138	268	55	0	0.083554863014069	1
"48"	"MAPK targets/ Nuclear events mediated by MAP kinases"	30	30	14	0.466666666666667	30	30	28	0.933333333333333	0.293918918918919	87	139	15	0	0.0866938769049286	1
"792"	"RNA Polymerase I Promoter Opening"	30	30	1	0.0333333333333333	30	30	28	0.933333333333333	0.111486486486486	33	91	10	0	0.0866938769049286	1
"113"	"EPHB-mediated forward signaling"	41	41	15	0.365853658536585	41	41	38	0.926829268292683	0.510135135135135	151	318	55	0	0.0873395907782534	1
"723"	"Condensation of Prophase Chromosomes"	41	41	2	0.0487804878048781	41	41	38	0.926829268292683	0.300675675675676	89	183	43	0	0.0873395907782534	1
"273"	"Signalling by NGF"	287	287	69	0.240418118466899	287	287	257	0.895470383275261	0.824324324324324	244	1831	82	0	0.0878271185986088	1
"270"	"Antigen processing-Cross presentation"	81	81	20	0.246913580246914	81	81	74	0.91358024691358	0.540540540540541	160	399	55	0	0.0889491655248523	1
"207"	"PI-3K cascade"	100	100	28	0.28	100	100	91	0.91	0.689189189189189	204	807	82	0	0.0889618280241276	1
"208"	"PI3K events in ERBB2 signaling"	100	100	28	0.28	100	100	91	0.91	0.689189189189189	204	807	82	0	0.0889618280241276	1
"209"	"PI3K events in ERBB4 signaling"	100	100	28	0.28	100	100	91	0.91	0.689189189189189	204	807	82	0	0.0889618280241276	1
"210"	"PI3K/AKT Signaling in Cancer"	100	100	28	0.28	100	100	91	0.91	0.689189189189189	204	807	82	0	0.0889618280241276	1
"211"	"PIP3 activates AKT signaling"	100	100	28	0.28	100	100	91	0.91	0.689189189189189	204	807	82	0	0.0889618280241276	1
"756"	"Sphingolipid metabolism"	71	71	3	0.0422535211267606	71	71	65	0.915492957746479	0.540540540540541	160	409	44	0	0.0909746770004833	1
"126"	"Nuclear Receptor transcription pathway"	51	51	18	0.352941176470588	51	51	47	0.92156862745098	0.324324324324324	96	204	21	0	0.0912147823953748	1
"763"	"Aquaporin-mediated transport"	51	51	2	0.0392156862745098	51	51	47	0.92156862745098	0.523648648648649	155	337	59	0	0.0912147823953748	1
"603"	"Ca2+ pathway"	61	61	6	0.0983606557377049	61	61	56	0.918032786885246	0.530405405405405	157	358	59	0	0.0919737131931737	1
"125"	"G1/S-Specific Transcription"	17	17	6	0.352941176470588	17	17	16	0.941176470588235	0.246621621621622	73	87	17	0	0.0959020837868141	1
"277"	"Metabolism of nitric oxide"	17	17	4	0.235294117647059	17	17	16	0.941176470588235	0.226351351351351	67	91	13	0	0.0959020837868141	1
"281"	"eNOS activation and regulation"	17	17	4	0.235294117647059	17	17	16	0.941176470588235	0.226351351351351	67	91	13	0	0.0959020837868141	1
"373"	"Energy dependent regulation of mTOR by LKB1-AMPK"	17	17	3	0.176470588235294	17	17	16	0.941176470588235	0.192567567567568	57	76	16	0	0.0959020837868141	1
"524"	"Activated point mutants of FGFR2"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.375	111	235	82	0	0.0959020837868141	1
"527"	"FGFR2 ligand binding and activation"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.375	111	235	82	0	0.0959020837868141	1
"530"	"Metabolism of porphyrins"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.192567567567568	57	70	14	0	0.0959020837868141	1
"531"	"PKA activation in glucagon signalling"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.290540540540541	86	107	31	0	0.0959020837868141	1
"532"	"Phosphorylation of the APC/C"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.114864864864865	34	47	11	0	0.0959020837868141	1
"534"	"Signaling by FGFR2 mutants"	17	17	2	0.117647058823529	17	17	16	0.941176470588235	0.375	111	235	82	0	0.0959020837868141	1
"217"	"Negative regulation of FGFR signaling"	40	40	11	0.275	40	40	37	0.925	0.506756756756757	150	432	82	0	0.096185615281025	1
"332"	"SHC-mediated cascade"	29	29	6	0.206896551724138	29	29	27	0.931034482758621	0.466216216216216	138	385	82	0	0.0968324491717764	1
"481"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	29	29	4	0.137931034482759	29	29	27	0.931034482758621	0.513513513513513	152	263	60	0	0.0968324491717764	1
"473"	"Nuclear Envelope Breakdown"	50	50	7	0.14	50	50	46	0.92	0.398648648648649	118	212	16	0	0.0994920871565417	1
"788"	"Cell-cell junction organization"	60	60	2	0.0333333333333333	60	60	55	0.916666666666667	0.527027027027027	156	568	57	0	0.0996414003837074	1
"156"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	69	69	22	0.318840579710145	69	69	63	0.91304347826087	0.483108108108108	143	294	55	0	0.105614278299258	1
"275"	"Synthesis of DNA"	97	97	23	0.237113402061856	97	97	88	0.907216494845361	0.614864864864865	182	529	55	0	0.107770420292096	1
"91"	"Degradation of GLI2 by the proteasome"	59	59	23	0.389830508474576	59	59	54	0.915254237288136	0.445945945945946	132	260	55	0	0.107858252431766	1
"92"	"GLI3 is processed to GLI3R by the proteasome"	59	59	23	0.389830508474576	59	59	54	0.915254237288136	0.439189189189189	130	257	55	0	0.107858252431766	1
"120"	"Degradation of GLI1 by the proteasome"	59	59	21	0.355932203389831	59	59	54	0.915254237288136	0.462837837837838	137	262	55	0	0.107858252431766	1
"90"	"Interleukin receptor SHC signaling"	28	28	11	0.392857142857143	28	28	26	0.928571428571429	0.408783783783784	121	242	60	0	0.10807009973277	1
"309"	"PKB-mediated events"	28	28	6	0.214285714285714	28	28	26	0.928571428571429	0.408783783783784	121	181	55	0	0.10807009973277	1
"71"	"Cross-presentation of soluble exogenous antigens (endosomes)"	49	49	20	0.408163265306122	49	49	45	0.918367346938776	0.408783783783784	121	234	55	0	0.108425183105465	1
"846"	"Amino acid and oligopeptide SLC transporters"	49	49	1	0.0204081632653061	49	49	45	0.918367346938776	0.391891891891892	116	235	26	0	0.108425183105465	1
"715"	"RNA Polymerase I Transcription"	78	78	4	0.0512820512820513	78	78	71	0.91025641025641	0.489864864864865	145	313	55	0	0.109833945854578	1
"104"	"Spry regulation of FGF signaling"	16	16	6	0.375	16	16	15	0.9375	0.168918918918919	50	60	15	0	0.110100161018632	1
"162"	"p75NTR signals via NF-kB"	16	16	5	0.3125	16	16	15	0.9375	0.39527027027027	117	143	57	0	0.110100161018632	1
"264"	"Nucleotide-like (purinergic) receptors"	16	16	4	0.25	16	16	15	0.9375	0.246621621621622	73	240	44	0	0.110100161018632	1
"364"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	16	16	3	0.1875	16	16	15	0.9375	0.168918918918919	50	66	19	0	0.110100161018632	1
"507"	"STING mediated induction of host immune responses"	16	16	2	0.125	16	16	15	0.9375	0.172297297297297	51	66	16	0	0.110100161018632	1
"780"	"Class B/2 (Secretin family receptors)"	87	87	3	0.0344827586206897	87	87	79	0.908045977011494	0.510135135135135	151	449	59	0	0.112766268545804	1
"302"	"DNA Replication"	105	105	23	0.219047619047619	105	105	95	0.904761904761905	0.641891891891892	190	572	55	0	0.115958564270382	1
"197"	"Regulation of APC/C activators between G1/S and early anaphase"	77	77	22	0.285714285714286	77	77	70	0.909090909090909	0.462837837837838	137	298	55	0	0.117656285363282	1
"560"	"Hemostasis"	497	497	55	0.110663983903421	497	497	441	0.887323943661972	0.807432432432432	239	3212	60	0	0.119406711201551	1
"154"	"Constitutive PI3K/AKT Signaling in Cancer"	86	86	28	0.325581395348837	86	86	78	0.906976744186046	0.64527027027027	191	731	82	0	0.120344209563216	1
"386"	"Cellular Senescence"	158	158	27	0.170886075949367	158	158	142	0.89873417721519	0.702702702702703	208	863	83	0	0.120468622883246	1
"297"	"mTOR signalling"	27	27	6	0.222222222222222	27	27	25	0.925925925925926	0.408783783783784	121	178	55	0	0.120509845126589	1
"433"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	27	27	4	0.148148148148148	27	27	25	0.925925925925926	0.331081081081081	98	144	25	0	0.120509845126589	1
"434"	"Synthesis of bile acids and bile salts"	27	27	4	0.148148148148148	27	27	25	0.925925925925926	0.256756756756757	76	120	15	0	0.120509845126589	1
"662"	"Detoxification of Reactive Oxygen Species"	27	27	2	0.0740740740740741	27	27	25	0.925925925925926	0.25	74	129	22	0	0.120509845126589	1
"190"	"GAB1 signalosome"	104	104	30	0.288461538461538	104	104	94	0.903846153846154	0.692567567567568	205	826	82	0	0.123038268603417	1
"710"	"RNA Polymerase I Promoter Clearance"	76	76	4	0.0526315789473684	76	76	69	0.907894736842105	0.489864864864865	145	307	55	0	0.125938021304009	1
"246"	"Constitutive Signaling by EGFRvIII"	15	15	4	0.266666666666667	15	15	14	0.933333333333333	0.375	111	138	60	0	0.12639777303556	1
"350"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	15	15	3	0.2	15	15	14	0.933333333333333	0.138513513513514	41	68	13	0	0.12639777303556	1
"353"	"p130Cas linkage to MAPK signaling for integrins"	15	15	3	0.2	15	15	14	0.933333333333333	0.283783783783784	84	108	34	0	0.12639777303556	1
"486"	"Depolymerisation of the Nuclear Lamina"	15	15	2	0.133333333333333	15	15	14	0.933333333333333	0.172297297297297	51	62	15	0	0.12639777303556	1
"487"	"Fatty acids"	15	15	2	0.133333333333333	15	15	14	0.933333333333333	0.0304054054054054	9	33	4	0	0.12639777303556	1
"673"	"NRIF signals cell death from the nucleus"	15	15	1	0.0666666666666667	15	15	14	0.933333333333333	0.148648648648649	44	59	9	0	0.12639777303556	1
"438"	"Cell Cycle, Mitotic"	445	445	64	0.143820224719101	445	445	395	0.887640449438202	0.851351351351351	252	2389	83	0	0.127545452398693	1
"705"	"Activation of ATR in response to replication stress"	37	37	2	0.0540540540540541	37	37	34	0.918918918918919	0.469594594594595	139	279	55	0	0.127770738160733	1
"39"	"Interleukin-2 signaling"	47	47	23	0.48936170212766	47	47	43	0.914893617021277	0.483108108108108	143	314	60	0	0.128416148541438	1
"175"	"NOTCH1 Intracellular Domain Regulates Transcription"	47	47	14	0.297872340425532	47	47	43	0.914893617021277	0.47972972972973	142	311	60	0	0.128416148541438	1
"877"	"Transport of inorganic cations/anions and amino acids/oligopeptides"	94	94	1	0.0106382978723404	94	94	85	0.904255319148936	0.540540540540541	160	472	36	0	0.129765098614586	1
"489"	"Cell Cycle"	518	518	68	0.131274131274131	518	518	459	0.886100386100386	0.85472972972973	253	2803	83	0	0.132900390813499	1
"64"	"Signaling by Leptin"	26	26	11	0.423076923076923	26	26	24	0.923076923076923	0.256756756756757	76	100	18	0	0.134261116727835	1
"427"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	26	26	4	0.153846153846154	26	26	24	0.923076923076923	0.331081081081081	98	143	25	0	0.134261116727835	1
"652"	"Downregulation of TGF-beta receptor signaling"	26	26	2	0.0769230769230769	26	26	24	0.923076923076923	0.27027027027027	80	117	23	0	0.134261116727835	1
"135"	"degradation of DVL"	56	56	19	0.339285714285714	56	56	51	0.910714285714286	0.432432432432432	128	309	60	0	0.136089208185282	1
"562"	"G alpha (z) signalling events"	46	46	5	0.108695652173913	46	46	42	0.91304347826087	0.459459459459459	136	293	59	0	0.139553823769449	1
"118"	"Activation of Rac"	14	14	5	0.357142857142857	14	14	13	0.928571428571429	0.337837837837838	100	147	51	0	0.145105024447907	1
"195"	"Golgi Cisternae Pericentriolar Stack Reorganization"	14	14	4	0.285714285714286	14	14	13	0.928571428571429	0.179054054054054	53	67	18	0	0.145105024447907	1
"198"	"Signal attenuation"	14	14	4	0.285714285714286	14	14	13	0.928571428571429	0.135135135135135	40	52	8	0	0.145105024447907	1
"310"	"Regulation of AMPK activity via LKB1"	14	14	3	0.214285714285714	14	14	13	0.928571428571429	0.172297297297297	51	64	16	0	0.145105024447907	1
"439"	"FGFR1 ligand binding and activation"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.415540540540541	123	261	82	0	0.145105024447907	1
"443"	"Leading Strand Synthesis"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.351351351351351	104	142	55	0	0.145105024447907	1
"444"	"Polymerase switching"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.351351351351351	104	142	55	0	0.145105024447907	1
"445"	"Polymerase switching on the C-strand of the telomere"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.351351351351351	104	142	55	0	0.145105024447907	1
"450"	"TRAF3-dependent IRF activation pathway"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.219594594594595	65	81	24	0	0.145105024447907	1
"40"	"Frs2-mediated activation"	25	25	12	0.48	25	25	23	0.92	0.277027027027027	82	127	18	0	0.149439407080154	1
"41"	"SHC-related events"	25	25	12	0.48	25	25	23	0.92	0.260135135135135	77	108	18	0	0.149439407080154	1
"42"	"SHC-related events triggered by IGF1R"	25	25	12	0.48	25	25	23	0.92	0.25	74	103	18	0	0.149439407080154	1
"411"	"Effects of PIP2 hydrolysis"	25	25	4	0.16	25	25	23	0.92	0.39527027027027	117	183	56	0	0.149439407080154	1
"761"	"TRP channels"	25	25	1	0.04	25	25	23	0.92	0.293918918918919	87	122	35	0	0.149439407080154	1
"551"	"Metabolism of amino acids and derivatives"	188	188	21	0.111702127659574	188	188	168	0.893617021276596	0.766891891891892	227	1005	60	0	0.149632097028377	1
"160"	"Hedgehog ligand biogenesis"	64	64	20	0.3125	64	64	58	0.90625	0.47972972972973	142	289	55	0	0.151184748539758	1
"161"	"Processing-defective Hh variants abrogate ligand secretion"	64	64	20	0.3125	64	64	58	0.90625	0.47972972972973	142	289	55	0	0.151184748539758	1
"748"	"NRAGE signals death through JNK"	45	45	2	0.0444444444444444	45	45	41	0.911111111111111	0.452702702702703	134	281	57	0	0.151506260460416	1
"878"	"Regulatory RNA pathways"	100	100	1	0.01	100	100	90	0.9	0.547297297297297	162	474	55	0	0.154914229868284	1
"231"	"DNA Replication Pre-Initiation"	82	82	22	0.268292682926829	82	82	74	0.902439024390244	0.577702702702703	171	420	55	0	0.154941672932261	1
"233"	"M/G1 Transition"	82	82	22	0.268292682926829	82	82	74	0.902439024390244	0.577702702702703	171	420	55	0	0.154941672932261	1
"300"	"Oxidative Stress Induced Senescence"	91	91	20	0.21978021978022	91	91	82	0.901098901098901	0.635135135135135	188	600	83	0	0.155260210813769	1
"729"	"GPCR downstream signaling"	966	966	46	0.0476190476190476	966	966	851	0.880952380952381	0.827702702702703	245	4657	60	0	0.156502820816635	1
"128"	"SCF-beta-TrCP mediated degradation of Emi1"	54	54	19	0.351851851851852	54	54	49	0.907407407407407	0.425675675675676	126	242	55	0	0.15817726882616	1
"767"	"Assembly of collagen fibrils and other multimeric structures"	54	54	2	0.037037037037037	54	54	49	0.907407407407407	0.472972972972973	140	374	32	0	0.15817726882616	1
"451"	"Signaling by WNT in cancer"	212	212	30	0.141509433962264	212	212	189	0.891509433962264	0.682432432432432	202	1088	60	0	0.159827311178579	1
"115"	"FRS2-mediated cascade"	44	44	16	0.363636363636364	44	44	40	0.909090909090909	0.550675675675676	163	459	82	0	0.164312924971386	1
"484"	"G2/M Checkpoints"	44	44	6	0.136363636363636	44	44	40	0.909090909090909	0.483108108108108	143	294	55	0	0.164312924971386	1
"68"	"Nuclear Events (kinase and transcription factor activation)"	24	24	10	0.416666666666667	24	24	22	0.916666666666667	0.243243243243243	72	113	15	0	0.166165672302452	1
"322"	"Growth hormone receptor signaling"	24	24	5	0.208333333333333	24	24	22	0.916666666666667	0.290540540540541	86	126	18	0	0.166165672302452	1
"323"	"Pyrimidine metabolism"	24	24	5	0.208333333333333	24	24	22	0.916666666666667	0.297297297297297	88	116	17	0	0.166165672302452	1
"395"	"IKK complex recruitment mediated by RIP1"	24	24	4	0.166666666666667	24	24	22	0.916666666666667	0.290540540540541	86	140	24	0	0.166165672302452	1
"404"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	24	24	4	0.166666666666667	24	24	22	0.916666666666667	0.216216216216216	64	103	15	0	0.166165672302452	1
"757"	"Cytosolic tRNA aminoacylation"	24	24	1	0.0416666666666667	24	24	22	0.916666666666667	0.216216216216216	64	93	14	0	0.166165672302452	1
"18"	"AKT phosphorylates targets in the cytosol"	13	13	7	0.538461538461538	13	13	12	0.923076923076923	0.179054054054054	53	61	16	0	0.166577769174827	1
"97"	"Downregulation of ERBB2:ERBB3 signaling"	13	13	5	0.384615384615385	13	13	12	0.923076923076923	0.162162162162162	48	55	15	0	0.166577769174827	1
"283"	"NF-kB is activated and signals survival"	13	13	3	0.230769230769231	13	13	12	0.923076923076923	0.212837837837838	63	70	12	0	0.166577769174827	1
"284"	"Purine salvage"	13	13	3	0.230769230769231	13	13	12	0.923076923076923	0.114864864864865	34	42	9	0	0.166577769174827	1
"285"	"Signaling by Activin"	13	13	3	0.230769230769231	13	13	12	0.923076923076923	0.239864864864865	71	88	31	0	0.166577769174827	1
"422"	"FGFR2c ligand binding and activation"	13	13	2	0.153846153846154	13	13	12	0.923076923076923	0.344594594594595	102	131	82	0	0.166577769174827	1
"423"	"FGFR4 ligand binding and activation"	13	13	2	0.153846153846154	13	13	12	0.923076923076923	0.341216216216216	101	208	82	0	0.166577769174827	1
"424"	"IRF3-mediated induction of type I IFN"	13	13	2	0.153846153846154	13	13	12	0.923076923076923	0.165540540540541	49	60	16	0	0.166577769174827	1
"426"	"Platelet Adhesion to exposed collagen"	13	13	2	0.153846153846154	13	13	12	0.923076923076923	0.277027027027027	82	111	53	0	0.166577769174827	1
"654"	"Initiation of Nuclear Envelope Reformation"	13	13	1	0.0769230769230769	13	13	12	0.923076923076923	0.206081081081081	61	72	16	0	0.166577769174827	1
"655"	"Nuclear Envelope Reassembly"	13	13	1	0.0769230769230769	13	13	12	0.923076923076923	0.206081081081081	61	72	16	0	0.166577769174827	1
"625"	"Factors involved in megakaryocyte development and platelet production"	125	125	11	0.088	125	125	112	0.896	0.64527027027027	191	849	59	0	0.167341903727871	1
"20"	"EPHA-mediated growth cone collapse"	34	34	18	0.529411764705882	34	34	31	0.911764705882353	0.391891891891892	116	186	34	0	0.168201975202254	1
"495"	"Signaling by Wnt"	286	286	36	0.125874125874126	286	286	254	0.888111888111888	0.72972972972973	216	1559	60	0	0.170209069713203	1
"356"	"Axon guidance"	327	327	63	0.192660550458716	327	327	290	0.886850152905199	0.790540540540541	234	1968	58	0	0.17356598185877	1
"714"	"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds"	97	97	5	0.0515463917525773	97	97	87	0.896907216494845	0.543918918918919	161	541	56	0	0.182800540278285	1
"98"	"Vpu mediated degradation of CD4"	52	52	20	0.384615384615385	52	52	47	0.903846153846154	0.425675675675676	126	236	55	0	0.183133814971046	1
"380"	"Apoptotic execution  phase"	52	52	9	0.173076923076923	52	52	47	0.903846153846154	0.47972972972973	142	312	51	0	0.183133814971046	1
"518"	"Nuclear Pore Complex (NPC) Disassembly"	33	33	4	0.121212121212121	33	33	30	0.909090909090909	0.280405405405405	83	125	16	0	0.183937190926625	1
"165"	"Endogenous sterols"	23	23	7	0.304347826086957	23	23	21	0.91304347826087	0.297297297297297	88	176	33	0	0.184565426399067	1
"305"	"FGFR ligand binding and activation"	23	23	5	0.217391304347826	23	23	21	0.91304347826087	0.429054054054054	127	357	82	0	0.184565426399067	1
"750"	"APC-Cdc20 mediated degradation of Nek2A"	23	23	1	0.0434782608695652	23	23	21	0.91304347826087	0.152027027027027	45	61	11	0	0.184565426399067	1
"794"	"Cell death signalling via NRAGE, NRIF and NADE"	61	61	2	0.0327868852459016	61	61	55	0.901639344262295	0.486486486486487	144	344	57	0	0.185519496917687	1
"494"	"Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell"	140	140	18	0.128571428571429	140	140	125	0.892857142857143	0.621621621621622	184	746	59	0	0.186672447415244	1
"3"	"Reversible hydration of carbon dioxide"	12	12	11	0.916666666666667	12	12	11	0.916666666666667	0.179054054054054	53	104	19	0	0.19122435186726	1
"26"	"CD28 dependent Vav1 pathway"	12	12	6	0.5	12	12	11	0.916666666666667	0.287162162162162	85	114	51	0	0.19122435186726	1
"34"	"PECAM1 interactions"	12	12	6	0.5	12	12	11	0.916666666666667	0.185810810810811	55	63	17	0	0.19122435186726	1
"262"	"Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis"	12	12	3	0.25	12	12	11	0.916666666666667	0.195945945945946	58	65	23	0	0.19122435186726	1
"392"	"FGFR3 ligand binding and activation"	12	12	2	0.166666666666667	12	12	11	0.916666666666667	0.351351351351351	104	128	82	0	0.19122435186726	1
"393"	"FGFR3c ligand binding and activation"	12	12	2	0.166666666666667	12	12	11	0.916666666666667	0.351351351351351	104	128	82	0	0.19122435186726	1
"397"	"P2Y receptors"	12	12	2	0.166666666666667	12	12	11	0.916666666666667	0.222972972972973	66	226	44	0	0.19122435186726	1
"401"	"Signaling by FGFR3 mutants"	12	12	2	0.166666666666667	12	12	11	0.916666666666667	0.351351351351351	104	128	82	0	0.19122435186726	1
"402"	"Signaling by activated point mutants of FGFR3"	12	12	2	0.166666666666667	12	12	11	0.916666666666667	0.351351351351351	104	128	82	0	0.19122435186726	1
"637"	"Death Receptor Signalling"	12	12	1	0.0833333333333333	12	12	11	0.916666666666667	0.449324324324324	133	203	85	0	0.19122435186726	1
"389"	"Amine ligand-binding receptors"	42	42	7	0.166666666666667	42	42	38	0.904761904761905	0.280405405405405	83	166	28	0	0.192641469895545	1
"503"	"Oncogene Induced Senescence"	32	32	4	0.125	32	32	29	0.90625	0.5	148	299	83	0	0.200905062303731	1
"658"	"Metabolism"	1565	1565	120	0.0766773162939297	1565	1565	1373	0.877316293929712	0.905405405405405	268	8103	60	0	0.201635220206522	1
"17"	"Signalling to p38 via RIT and RIN"	22	22	12	0.545454545454545	22	22	20	0.909090909090909	0.246621621621622	73	106	18	0	0.204767449710415	1
"38"	"SHC-mediated signalling"	22	22	11	0.5	22	22	20	0.909090909090909	0.243243243243243	72	95	18	0	0.204767449710415	1
"290"	"Extrinsic Pathway"	22	22	5	0.227272727272727	22	22	20	0.909090909090909	0.506756756756757	150	249	85	0	0.204767449710415	1
"743"	"Common Pathway"	22	22	1	0.0454545454545455	22	22	20	0.909090909090909	0.226351351351351	67	98	11	0	0.204767449710415	1
"745"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	22	22	1	0.0454545454545455	22	22	20	0.909090909090909	0.358108108108108	106	198	60	0	0.204767449710415	1
"746"	"Pyruvate metabolism"	22	22	1	0.0454545454545455	22	22	20	0.909090909090909	0.277027027027027	82	126	15	0	0.204767449710415	1
"747"	"Smooth Muscle Contraction"	22	22	1	0.0454545454545455	22	22	20	0.909090909090909	0.27027027027027	80	124	19	0	0.204767449710415	1
"515"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	41	41	5	0.121951219512195	41	41	37	0.902439024390244	0.638513513513513	189	431	79	0	0.208235258982798	1
"646"	"Lipid digestion, mobilization, and transport"	50	50	4	0.08	50	50	45	0.9	0.344594594594595	102	188	23	0	0.211155786518083	1
"221"	"Signaling by ERBB4"	154	154	42	0.272727272727273	154	154	137	0.88961038961039	0.763513513513513	226	1065	82	0	0.212859834454408	1
"563"	"PPARA activates gene expression"	111	111	12	0.108108108108108	111	111	99	0.891891891891892	0.658783783783784	195	613	60	0	0.217011512362468	1
"116"	"Interleukin-6 signaling"	11	11	4	0.363636363636364	11	11	10	0.909090909090909	0.175675675675676	52	61	18	0	0.219513341552956	1
"117"	"Transport of organic anions"	11	11	4	0.363636363636364	11	11	10	0.909090909090909	0.131756756756757	39	57	20	0	0.219513341552956	1
"218"	"Condensation of Prometaphase Chromosomes"	11	11	3	0.272727272727273	11	11	10	0.909090909090909	0.209459459459459	62	72	43	0	0.219513341552956	1
"223"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	11	11	3	0.272727272727273	11	11	10	0.909090909090909	0.243243243243243	72	96	43	0	0.219513341552956	1
"368"	"FGFR1c ligand binding and activation"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.388513513513513	115	158	82	0	0.219513341552956	1
"369"	"Import of palmitoyl-CoA into the mitochondrial matrix"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.209459459459459	62	67	41	0	0.219513341552956	1
"371"	"Signaling by activated point mutants of FGFR1"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.388513513513513	115	158	82	0	0.219513341552956	1
"372"	"mTORC1-mediated signalling"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.290540540540541	86	106	55	0	0.219513341552956	1
"614"	"Androgen biosynthesis"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.14527027027027	43	56	20	0	0.219513341552956	1
"615"	"Base-free sugar-phosphate removal via the single-nucleotide replacement pathway"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.125	37	44	14	0	0.219513341552956	1
"617"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.118243243243243	35	66	11	0	0.219513341552956	1
"618"	"Heme biosynthesis"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.165540540540541	49	54	14	0	0.219513341552956	1
"620"	"Nicotinate metabolism"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.297297297297297	88	113	54	0	0.219513341552956	1
"621"	"Tryptophan catabolism"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.114864864864865	34	59	20	0	0.219513341552956	1
"292"	"Semaphorin interactions"	67	67	15	0.223880597014925	67	67	60	0.895522388059702	0.516891891891892	153	386	51	0	0.223753200990388	1
"498"	"Activation of gene expression by SREBF (SREBP)"	40	40	5	0.125	40	40	36	0.9	0.608108108108108	180	327	60	0	0.224825791527268	1
"716"	"G alpha (i) signalling events"	236	236	12	0.0508474576271186	236	236	209	0.885593220338983	0.668918918918919	198	1363	59	0	0.225241085210521	1
"847"	"Muscle contraction"	49	49	1	0.0204081632653061	49	49	44	0.897959183673469	0.398648648648649	118	229	19	0	0.226369373758776	1
"23"	"SOS-mediated signalling"	21	21	11	0.523809523809524	21	21	19	0.904761904761905	0.25	74	91	18	0	0.226902017538394	1
"58"	"ERK/MAPK targets"	21	21	9	0.428571428571429	21	21	19	0.904761904761905	0.226351351351351	67	103	15	0	0.226902017538394	1
"609"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	21	21	2	0.0952380952380952	21	21	19	0.904761904761905	0.10472972972973	31	58	6	0	0.226902017538394	1
"378"	"beta-catenin independent WNT signaling"	144	144	25	0.173611111111111	144	144	128	0.888888888888889	0.641891891891892	190	871	60	0	0.226997244946462	1
"693"	"Response to elevated platelet cytosolic Ca2+"	84	84	5	0.0595238095238095	84	84	75	0.892857142857143	0.533783783783784	158	495	56	0	0.229829845777181	1
"758"	"G alpha (12/13) signalling events"	75	75	3	0.04	75	75	67	0.893333333333333	0.52027027027027	154	502	60	0	0.233817174720095	1
"616"	"Cytosolic sensors of pathogen-associated DNA"	66	66	6	0.0909090909090909	66	66	59	0.893939393939394	0.540540540540541	160	360	55	0	0.237446346776527	1
"169"	"APC/C-mediated degradation of cell cycle proteins"	83	83	25	0.301204819277108	83	83	74	0.891566265060241	0.493243243243243	146	320	55	0	0.242305909374543	1
"170"	"Regulation of mitotic cell cycle"	83	83	25	0.301204819277108	83	83	74	0.891566265060241	0.493243243243243	146	320	55	0	0.242305909374543	1
"141"	"G beta:gamma signalling through PI3Kgamma"	48	48	16	0.333333333333333	48	48	43	0.895833333333333	0.449324324324324	133	378	60	0	0.242407699179073	1
"816"	"Formation of Fibrin Clot (Clotting Cascade)"	39	39	1	0.0256410256410256	39	39	35	0.897435897435897	0.412162162162162	122	302	56	0	0.242441597909272	1
"817"	"Glycosphingolipid metabolism"	39	39	1	0.0256410256410256	39	39	35	0.897435897435897	0.358108108108108	106	234	25	0	0.242441597909272	1
"753"	"Chromatin modifying enzymes"	208	208	9	0.0432692307692308	208	208	184	0.884615384615385	0.736486486486487	218	1231	80	0	0.250604364914238	1
"754"	"Chromatin organization"	208	208	9	0.0432692307692308	208	208	184	0.884615384615385	0.736486486486487	218	1231	80	0	0.250604364914238	1
"338"	"Formation of tubulin folding intermediates by CCT/TriC"	20	20	4	0.2	20	20	18	0.9	0.287162162162162	85	114	25	0	0.251098535698407	1
"343"	"Regulation of gene expression in beta cells"	20	20	4	0.2	20	20	18	0.9	0.368243243243243	109	157	56	0	0.251098535698407	1
"349"	"Signaling by Hippo"	20	20	4	0.2	20	20	18	0.9	0.300675675675676	89	148	43	0	0.251098535698407	1
"4"	"Activation of the AP-1 family of transcription factors"	10	10	8	0.8	10	10	9	0.9	0.114864864864865	34	37	13	0	0.251982403370248	1
"80"	"IRAK1 recruits IKK complex"	10	10	4	0.4	10	10	9	0.9	0.179054054054054	53	70	19	0	0.251982403370248	1
"81"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	10	10	4	0.4	10	10	9	0.9	0.179054054054054	53	70	19	0	0.251982403370248	1
"83"	"Role of DCC in regulating apoptosis"	10	10	4	0.4	10	10	9	0.9	0.131756756756757	39	46	14	0	0.251982403370248	1
"84"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	10	10	4	0.4	10	10	9	0.9	0.114864864864865	34	47	8	0	0.251982403370248	1
"173"	"Regulation of signaling by NODAL"	10	10	3	0.3	10	10	9	0.9	0.0912162162162162	27	34	13	0	0.251982403370248	1
"339"	"GP1b-IX-V activation signalling"	10	10	2	0.2	10	10	9	0.9	0.290540540540541	86	108	53	0	0.251982403370248	1
"342"	"Regulation of Rheb GTPase activity by AMPK"	10	10	2	0.2	10	10	9	0.9	0.138513513513514	41	49	16	0	0.251982403370248	1
"592"	"Acetylcholine regulates insulin secretion"	10	10	1	0.1	10	10	9	0.9	0.0777027027027027	23	30	7	0	0.251982403370248	1
"594"	"Alpha-defensins"	10	10	1	0.1	10	10	9	0.9	0.121621621621622	36	88	14	0	0.251982403370248	1
"600"	"Methylation"	10	10	1	0.1	10	10	9	0.9	0.148648648648649	44	51	21	0	0.251982403370248	1
"601"	"Purine catabolism"	10	10	1	0.1	10	10	9	0.9	0.0912162162162162	27	31	8	0	0.251982403370248	1
"382"	"Mitotic G2-G2/M phases"	116	116	20	0.172413793103448	116	116	103	0.887931034482759	0.567567567567568	168	540	34	0	0.254737332066343	1
"226"	"AMER1 mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"227"	"APC truncation mutants are not K63 polyubiquitinated"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"228"	"APC truncation mutants have impaired AXIN binding"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"229"	"AXIN missense mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"230"	"AXIN mutants destabilize the destruction complex, activating WNT signaling"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"232"	"Degradation of beta-catenin by the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"234"	"S33 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"235"	"S37 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"236"	"S45 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"237"	"T41 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"238"	"TCF7L2 mutants don't bind CTBP"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"239"	"deletions in the AMER1 gene destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"240"	"deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"241"	"misspliced GSK3beta mutants stabilize beta-catenin"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"242"	"phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"243"	"truncated APC mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"244"	"truncations of AMER1 destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	73	0.890243902439024	0.510135135135135	151	346	55	0	0.255247774970708	1
"516"	"Cell surface interactions at the vascular wall"	99	99	12	0.121212121212121	99	99	88	0.888888888888889	0.625	185	568	60	0	0.25581922570434	1
"859"	"RNA Polymerase I Chain Elongation"	56	56	1	0.0178571428571429	56	56	50	0.892857142857143	0.398648648648649	118	226	55	0	0.255914507484511	1
"158"	"Toll Like Receptor 4 (TLR4) Cascade"	124	124	39	0.314516129032258	124	124	110	0.887096774193548	0.638513513513513	189	659	85	0	0.259218971516283	1
"680"	"RNA Polymerase I Transcription Initiation"	47	47	3	0.0638297872340425	47	47	42	0.893617021276596	0.462837837837838	137	217	55	0	0.259283832470567	1
"384"	"The role of Nef in HIV-1 replication and disease pathogenesis"	29	29	5	0.172413793103448	29	29	26	0.896551724137931	0.432432432432432	128	243	58	0	0.259778382306189	1
"590"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	29	29	3	0.103448275862069	29	29	26	0.896551724137931	0.574324324324324	170	322	79	0	0.259778382306189	1
"781"	"Interaction between L1 and Ankyrins"	29	29	1	0.0344827586206897	29	29	26	0.896551724137931	0.307432432432432	91	171	30	0	0.259778382306189	1
"315"	"Apoptotic cleavage of cellular proteins"	38	38	8	0.210526315789474	38	38	34	0.894736842105263	0.381756756756757	113	225	34	0	0.261106788584367	1
"136"	"Activated TLR4 signalling"	115	115	39	0.339130434782609	115	115	102	0.88695652173913	0.638513513513513	189	637	85	0	0.266059869629885	1
"258"	"Apoptosis"	148	148	38	0.256756756756757	148	148	131	0.885135135135135	0.695945945945946	206	889	85	0	0.270009148404818	1
"649"	"Fatty acid, triacylglycerol, and ketone body metabolism"	181	181	14	0.0773480662983425	181	181	160	0.883977900552486	0.726351351351351	215	1007	60	0	0.270657881210215	1
"770"	"ECM proteoglycans"	55	55	2	0.0363636363636364	55	55	49	0.890909090909091	0.331081081081081	98	199	15	0	0.272071000860625	1
"643"	"Metabolism of lipids and lipoproteins"	569	569	46	0.0808435852372583	569	569	500	0.878734622144112	0.85472972972973	253	3005	60	0	0.272286159913851	1
"833"	"Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"834"	"Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"835"	"Defective GGT1 causes Glutathionuria (GLUTH)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"836"	"Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"837"	"Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"838"	"Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"839"	"Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"840"	"Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"841"	"Defective UGT1A1 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"842"	"Defective UGT1A4 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"843"	"Phase II conjugation"	89	89	2	0.0224719101123595	89	89	79	0.887640449438202	0.483108108108108	143	380	32	0	0.275151282583475	1
"22"	"Ephrin signaling"	19	19	10	0.526315789473684	19	19	17	0.894736842105263	0.385135135135135	114	232	55	0	0.277482446832483	1
"416"	"Signaling by NODAL"	19	19	3	0.157894736842105	19	19	17	0.894736842105263	0.273648648648649	81	112	31	0	0.277482446832483	1
"376"	"G2/M Transition"	114	114	20	0.175438596491228	114	114	101	0.885964912280702	0.560810810810811	166	523	34	0	0.277701869363903	1
"568"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	114	114	12	0.105263157894737	114	114	101	0.885964912280702	0.658783783783784	195	617	60	0	0.277701869363903	1
"627"	"Orphan transporters"	114	114	10	0.087719298245614	114	114	101	0.885964912280702	0.679054054054054	201	616	85	0	0.277701869363903	1
"355"	"L1CAM interactions"	97	97	19	0.195876288659794	97	97	86	0.88659793814433	0.665540540540541	197	611	58	0	0.280703298487633	1
"271"	"Platelet Aggregation (Plug Formation)"	37	37	9	0.243243243243243	37	37	33	0.891891891891892	0.493243243243243	146	299	55	0	0.280840120914638	1
"477"	"Signaling by NOTCH"	122	122	17	0.139344262295082	122	122	108	0.885245901639344	0.675675675675676	200	767	80	0	0.281651752228788	1
"775"	"mRNA Capping"	28	28	1	0.0357142857142857	28	28	25	0.892857142857143	0.344594594594595	102	192	55	0	0.282226535246239	1
"387"	"Developmental Biology"	519	519	87	0.167630057803468	519	519	456	0.878612716763006	0.841216216216216	249	3114	60	0	0.283489003323387	1
"129"	"Vif-mediated degradation of APOBEC3G"	54	54	19	0.351851851851852	54	54	48	0.888888888888889	0.452702702702703	134	250	55	0	0.288930724526939	1
"701"	"Meiotic recombination"	54	54	3	0.0555555555555556	54	54	48	0.888888888888889	0.283783783783784	84	189	15	0	0.288930724526939	1
"9"	"ERK2 activation"	9	9	6	0.666666666666667	9	9	8	0.888888888888889	0.155405405405405	46	50	18	0	0.289248475675909	1
"54"	"Nef and signal transduction"	9	9	4	0.444444444444444	9	9	8	0.888888888888889	0.22972972972973	68	77	51	0	0.289248475675909	1
"553"	"Gamma-carboxylation of protein precursors"	9	9	1	0.111111111111111	9	9	8	0.888888888888889	0.114864864864865	34	63	11	0	0.289248475675909	1
"556"	"Removal of aminoterminal propeptides from gamma-carboxylated proteins"	9	9	1	0.111111111111111	9	9	8	0.888888888888889	0.114864864864865	34	64	11	0	0.289248475675909	1
"906"	"Rho GTPase cycle"	121	121	1	0.00826446280991736	121	121	107	0.884297520661157	0.628378378378378	186	573	57	0	0.293307419840271	1
"907"	"Signaling by Rho GTPases"	121	121	1	0.00826446280991736	121	121	107	0.884297520661157	0.628378378378378	186	573	57	0	0.293307419840271	1
"820"	"Transcription"	203	203	5	0.0246305418719212	203	203	179	0.881773399014778	0.682432432432432	202	902	55	0	0.294692669302449	1
"65"	"Interleukin-3, 5 and GM-CSF signaling"	45	45	19	0.422222222222222	45	45	40	0.888888888888889	0.523648648648649	155	328	60	0	0.295581236208835	1
"717"	"Platelet degranulation"	79	79	4	0.0506329113924051	79	79	70	0.886075949367089	0.530405405405405	157	486	56	0	0.296856043524356	1
"318"	"Loss of Nlp from mitotic centrosomes"	62	62	13	0.209677419354839	62	62	55	0.887096774193548	0.466216216216216	138	334	32	0	0.298202828470649	1
"319"	"Loss of proteins required for interphase microtubule organizationfrom the centrosome"	62	62	13	0.209677419354839	62	62	55	0.887096774193548	0.466216216216216	138	334	32	0	0.298202828470649	1
"178"	"Integrin alphaIIb beta3 signaling"	27	27	8	0.296296296296296	27	27	24	0.888888888888889	0.364864864864865	108	155	34	0	0.306152011743409	1
"768"	"Attenuation phase"	27	27	1	0.037037037037037	27	27	24	0.888888888888889	0.371621621621622	110	185	33	0	0.306152011743409	1
"769"	"Kinesins"	27	27	1	0.037037037037037	27	27	24	0.888888888888889	0.209459459459459	62	86	18	0	0.306152011743409	1
"35"	"Regulation of signaling by CBL"	18	18	9	0.5	18	18	16	0.888888888888889	0.358108108108108	106	159	60	0	0.306171244114772	1
"555"	"Removal of DNA patch containing abasic residue"	18	18	2	0.111111111111111	18	18	16	0.888888888888889	0.222972972972973	66	91	23	0	0.306171244114772	1
"557"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	18	18	2	0.111111111111111	18	18	16	0.888888888888889	0.222972972972973	66	91	23	0	0.306171244114772	1
"513"	"M Phase"	266	266	33	0.12406015037594	266	266	234	0.879699248120301	0.702702702702703	208	1122	55	0	0.31111752999826	1
"282"	"Metabolism of nucleotides"	78	78	18	0.230769230769231	78	78	69	0.884615384615385	0.530405405405405	157	367	43	0	0.311639833608765	1
"250"	"Programmed Cell Death"	160	160	42	0.2625	160	160	141	0.88125	0.702702702702703	208	944	85	0	0.316758643432437	1
"851"	"Glycogen storage diseases"	257	257	5	0.0194552529182879	257	257	226	0.879377431906615	0.746621621621622	221	1297	60	0	0.319022269215547	1
"852"	"Metabolism of carbohydrates"	257	257	5	0.0194552529182879	257	257	226	0.879377431906615	0.746621621621622	221	1297	60	0	0.319022269215547	1
"853"	"Myoclonic epilepsy of Lafora"	257	257	5	0.0194552529182879	257	257	226	0.879377431906615	0.746621621621622	221	1297	60	0	0.319022269215547	1
"163"	"EPH-Ephrin signaling"	94	94	29	0.308510638297872	94	94	83	0.882978723404255	0.601351351351351	178	642	58	0	0.320817438438884	1
"698"	"Glucose metabolism"	69	69	4	0.0579710144927536	69	69	61	0.884057971014493	0.510135135135135	151	362	42	0	0.321514827221347	1
"385"	"HSF1-dependent transactivation"	35	35	6	0.171428571428571	35	35	31	0.885714285714286	0.378378378378378	112	196	33	0	0.323553313913689	1
"856"	"Metabolism of proteins"	694	694	13	0.0187319884726225	694	694	608	0.876080691642651	0.824324324324324	244	4255	60	0	0.328861102187139	1
"776"	"Cell junction organization"	85	85	3	0.0352941176470588	85	85	75	0.882352941176471	0.614864864864865	182	698	57	0	0.331260612019561	1
"358"	"ZBP1(DAI) mediated induction of type I IFNs"	26	26	5	0.192307692307692	26	26	23	0.884615384615385	0.263513513513513	78	109	12	0	0.331578891307977	1
"766"	"RNA Pol II CTD phosphorylation and interaction with CE"	26	26	1	0.0384615384615385	26	26	23	0.884615384615385	0.337837837837838	100	137	55	0	0.331578891307977	1
"33"	"Neurotransmitter Clearance In The Synaptic Cleft"	8	8	4	0.5	8	8	7	0.875	0.300675675675676	89	113	49	0	0.332019444372452	1
"102"	"Glucocorticoid biosynthesis"	8	8	3	0.375	8	8	7	0.875	0.165540540540541	49	91	33	0	0.332019444372452	1
"263"	"HuR stabilizes mRNA"	8	8	2	0.25	8	8	7	0.875	0.0506756756756757	15	21	5	0	0.332019444372452	1
"500"	"Downregulation of ERBB4 signaling"	8	8	1	0.125	8	8	7	0.875	0.114864864864865	34	38	12	0	0.332019444372452	1
"508"	"Sema4D mediated inhibition of cell attachment and migration"	8	8	1	0.125	8	8	7	0.875	0.0540540540540541	16	19	6	0	0.332019444372452	1
"509"	"Synthesis of PG"	8	8	1	0.125	8	8	7	0.875	0.246621621621622	73	78	56	0	0.332019444372452	1
"512"	"Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus"	8	8	1	0.125	8	8	7	0.875	0.111486486486486	33	62	11	0	0.332019444372452	1
"675"	"Telomere Maintenance"	60	60	4	0.0666666666666667	60	60	53	0.883333333333333	0.47972972972973	142	319	55	0	0.332142804582063	1
"12"	"RAF/MAP kinase cascade"	17	17	10	0.588235294117647	17	17	15	0.882352941176471	0.219594594594595	65	76	18	0	0.337269396727727	1
"525"	"Beta-catenin phosphorylation cascade"	17	17	2	0.117647058823529	17	17	15	0.882352941176471	0.226351351351351	67	82	15	0	0.337269396727727	1
"526"	"Butyrate Response Factor 1 (BRF1) destabilizes mRNA"	17	17	2	0.117647058823529	17	17	15	0.882352941176471	0.327702702702703	97	125	34	0	0.337269396727727	1
"533"	"Platelet sensitization by LDL"	17	17	2	0.117647058823529	17	17	15	0.882352941176471	0.199324324324324	59	78	15	0	0.337269396727727	1
"697"	"Tristetraprolin (TTP) destabilizes mRNA"	17	17	1	0.0588235294117647	17	17	15	0.882352941176471	0.320945945945946	95	120	34	0	0.337269396727727	1
"690"	"Signaling by GPCR"	1078	1078	66	0.0612244897959184	1078	1078	943	0.874768089053803	0.85472972972973	253	5125	60	0	0.341919506026102	1
"415"	"RNF mutants show enhanced WNT signaling and proliferation"	190	190	30	0.157894736842105	190	190	167	0.878947368421053	0.662162162162162	196	994	60	0	0.342249322301713	1
"417"	"TCF dependent signaling in response to WNT"	190	190	30	0.157894736842105	190	190	167	0.878947368421053	0.662162162162162	196	994	60	0	0.342249322301713	1
"418"	"XAV939 inhibits tankyrase, stabilizing AXIN"	190	190	30	0.157894736842105	190	190	167	0.878947368421053	0.662162162162162	196	994	60	0	0.342249322301713	1
"419"	"misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling"	190	190	30	0.157894736842105	190	190	167	0.878947368421053	0.662162162162162	196	994	60	0	0.342249322301713	1
"159"	"G-protein beta:gamma signalling"	51	51	16	0.313725490196078	51	51	45	0.882352941176471	0.459459459459459	136	390	60	0	0.34368517596214	1
"354"	"PI Metabolism"	51	51	10	0.196078431372549	51	51	45	0.882352941176471	0.459459459459459	136	306	60	0	0.34368517596214	1
"21"	"Signalling to RAS"	34	34	18	0.529411764705882	34	34	30	0.882352941176471	0.277027027027027	82	136	18	0	0.346534420078466	1
"629"	"Interferon gamma signaling"	92	92	8	0.0869565217391304	92	92	81	0.880434782608696	0.445945945945946	132	334	18	0	0.349340919109434	1
"727"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	42	42	2	0.0476190476190476	42	42	37	0.880952380952381	0.408783783783784	121	265	55	0	0.3563762553117	1
"731"	"HIV Transcription Elongation"	42	42	2	0.0476190476190476	42	42	37	0.880952380952381	0.408783783783784	121	265	55	0	0.3563762553117	1
"736"	"Tat-mediated elongation of the HIV-1 transcript"	42	42	2	0.0476190476190476	42	42	37	0.880952380952381	0.408783783783784	121	265	55	0	0.3563762553117	1
"412"	"RORA activates circadian gene expression"	25	25	4	0.16	25	25	22	0.88	0.462837837837838	137	199	60	0	0.358517722358878	1
"301"	"PCP/CE pathway"	91	91	20	0.21978021978022	91	91	80	0.879120879120879	0.577702702702703	171	576	60	0	0.364107829614341	1
"122"	"MyD88-independent cascade"	99	99	35	0.353535353535354	99	99	87	0.878787878787879	0.618243243243243	183	550	85	0	0.366097445816977	1
"123"	"TRIF-mediated TLR3/TLR4 signaling"	99	99	35	0.353535353535354	99	99	87	0.878787878787879	0.618243243243243	183	550	85	0	0.366097445816977	1
"124"	"Toll Like Receptor 3 (TLR3) Cascade"	99	99	35	0.353535353535354	99	99	87	0.878787878787879	0.618243243243243	183	550	85	0	0.366097445816977	1
"784"	"formation of the beta-catenin:TCF transactivating complex"	58	58	2	0.0344827586206897	58	58	51	0.879310344827586	0.425675675675676	126	283	36	0	0.368359965322424	1
"712"	"DNA Repair"	115	115	6	0.0521739130434783	115	115	101	0.878260869565217	0.587837837837838	174	584	55	0	0.369046790353889	1
"633"	"Organelle biogenesis and maintenance"	323	323	27	0.0835913312693498	323	323	283	0.876160990712074	0.763513513513513	226	1844	60	0	0.36934331980679	1
"220"	"Purine metabolism"	33	33	9	0.272727272727273	33	33	29	0.878787878787879	0.287162162162162	85	139	43	0	0.370583776074788	1
"362"	"Polo-like kinase mediated events"	16	16	3	0.1875	16	16	14	0.875	0.101351351351351	30	39	9	0	0.370861953289472	1
"502"	"Metabolism of Angiotensinogen to Angiotensins"	16	16	2	0.125	16	16	14	0.875	0.222972972972973	66	186	44	0	0.370861953289472	1
"687"	"TRAF6 mediated induction of TAK1 complex"	16	16	1	0.0625	16	16	14	0.875	0.192567567567568	57	73	15	0	0.370861953289472	1
"6"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	7	7	5	0.714285714285714	7	7	6	0.857142857142857	0.0608108108108108	18	20	8	0	0.381107534461845	1
"7"	"CREB phosphorylation"	7	7	5	0.714285714285714	7	7	6	0.857142857142857	0.101351351351351	30	31	12	0	0.381107534461845	1
"60"	"MEK activation"	7	7	3	0.428571428571429	7	7	6	0.857142857142857	0.0743243243243243	22	25	9	0	0.381107534461845	1
"61"	"RAF phosphorylates MEK"	7	7	3	0.428571428571429	7	7	6	0.857142857142857	0.0743243243243243	22	25	9	0	0.381107534461845	1
"194"	"FGFR3b ligand binding and activation"	7	7	2	0.285714285714286	7	7	6	0.857142857142857	0.0709459459459459	21	31	10	0	0.381107534461845	1
"59"	"GPVI-mediated activation cascade"	49	49	21	0.428571428571429	49	49	43	0.877551020408163	0.449324324324324	133	284	60	0	0.383544962877693	1
"490"	"Cell-Cell communication"	130	130	17	0.130769230769231	130	130	114	0.876923076923077	0.679054054054054	201	1036	60	0	0.383715167849373	1
"325"	"Sema4D induced cell migration and growth-cone collapse"	24	24	5	0.208333333333333	24	24	21	0.875	0.216216216216216	64	79	16	0	0.386962721461834	1
"405"	"TRAF6 mediated NF-kB activation"	24	24	4	0.166666666666667	24	24	21	0.875	0.277027027027027	82	105	12	0	0.386962721461834	1
"303"	"Signaling by Robo receptor"	32	32	7	0.21875	32	32	28	0.875	0.442567567567568	131	281	51	0	0.395676745981414	1
"806"	"Formation of the Early Elongation Complex"	32	32	1	0.03125	32	32	28	0.875	0.378378378378378	112	216	55	0	0.395676745981414	1
"807"	"Formation of the HIV-1 Early Elongation Complex"	32	32	1	0.03125	32	32	28	0.875	0.378378378378378	112	216	55	0	0.395676745981414	1
"409"	"Cellular responses to stress"	248	248	40	0.161290322580645	248	248	217	0.875	0.790540540540541	234	1351	83	0	0.400652753770433	1
"31"	"MAP kinase activation in TLR cascade"	56	56	28	0.5	56	56	49	0.875	0.435810810810811	129	260	18	0	0.406708445661574	1
"320"	"Centrosome maturation"	72	72	15	0.208333333333333	72	72	63	0.875	0.513513513513513	152	390	34	0	0.409263062510765	1
"324"	"Recruitment of mitotic centrosome proteins and complexes"	72	72	15	0.208333333333333	72	72	63	0.875	0.513513513513513	152	390	34	0	0.409263062510765	1
"377"	"Regulation of PLK1 Activity at G2/M Transition"	80	80	14	0.175	80	80	70	0.875	0.483108108108108	143	380	32	0	0.409905446806205	1
"95"	"MyD88 dependent cascade initiated on endosome"	88	88	34	0.386363636363636	88	88	77	0.875	0.547297297297297	162	441	43	0	0.410269928093618	1
"96"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	88	88	34	0.386363636363636	88	88	77	0.875	0.547297297297297	162	441	43	0	0.410269928093618	1
"103"	"MyD88:Mal cascade initiated on plasma membrane"	96	96	36	0.375	96	96	84	0.875	0.547297297297297	162	438	19	0	0.410423199332919	1
"105"	"Toll Like Receptor 2 (TLR2) Cascade"	96	96	36	0.375	96	96	84	0.875	0.547297297297297	162	438	19	0	0.410423199332919	1
"106"	"Toll Like Receptor TLR1:TLR2 Cascade"	96	96	36	0.375	96	96	84	0.875	0.547297297297297	162	438	19	0	0.410423199332919	1
"107"	"Toll Like Receptor TLR6:TLR2 Cascade"	96	96	36	0.375	96	96	84	0.875	0.547297297297297	162	438	19	0	0.410423199332919	1
"306"	"Signaling by BMP"	23	23	5	0.217391304347826	23	23	20	0.869565217391304	0.263513513513513	78	102	19	0	0.416888694479564	1
"492"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	23	23	3	0.130434782608696	23	23	20	0.869565217391304	0.398648648648649	118	163	57	0	0.416888694479564	1
"605"	"disassembly of the destruction complex and recruitment of AXIN to the membrane"	31	31	3	0.0967741935483871	31	31	27	0.870967741935484	0.415540540540541	123	206	60	0	0.421776291326212	1
"679"	"Gluconeogenesis"	31	31	2	0.0645161290322581	31	31	27	0.870967741935484	0.266891891891892	79	149	20	0	0.421776291326212	1
"800"	"Pausing and recovery of Tat-mediated HIV elongation"	31	31	1	0.032258064516129	31	31	27	0.870967741935484	0.39527027027027	117	193	55	0	0.421776291326212	1
"803"	"Tat-mediated HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	27	0.870967741935484	0.39527027027027	117	193	55	0	0.421776291326212	1
"70"	"Activation of NMDA receptor upon glutamate binding and postsynaptic events"	39	39	16	0.41025641025641	39	39	34	0.871794871794872	0.361486486486487	107	164	31	0	0.424427206991455	1
"812"	"MHC class II antigen presentation"	103	103	3	0.029126213592233	103	103	90	0.87378640776699	0.554054054054054	164	527	58	0	0.425106112427229	1
"718"	"Platelet homeostasis"	79	79	4	0.0506329113924051	79	79	69	0.873417721518987	0.537162162162162	159	518	60	0	0.42662486759861	1
"408"	"Cytokine Signaling in Immune system"	308	308	51	0.165584415584416	308	308	269	0.873376623376623	0.773648648648649	229	1774	60	0	0.429364381692396	1
"1"	"RSK activation"	6	6	6	1	6	6	5	0.833333333333333	0.0777027027027027	23	25	12	0	0.437444671123222	1
"140"	"DNA replication initiation"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.125	37	41	14	0	0.437444671123222	1
"142"	"Klotho-mediated ligand binding"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.361486486486487	107	123	81	0	0.437444671123222	1
"144"	"Phosphorylation of Emi1"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.0371621621621622	11	11	3	0	0.437444671123222	1
"147"	"Telomere C-strand synthesis initiation"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.125	37	41	14	0	0.437444671123222	1
"149"	"Uptake and function of diphtheria toxin"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.0810810810810811	24	24	7	0	0.437444671123222	1
"396"	"Nonhomologous End-joining (NHEJ)"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.108108108108108	32	32	16	0	0.437444671123222	1
"400"	"Release of eIF4E"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.121621621621622	36	38	28	0	0.437444671123222	1
"407"	"vRNP Assembly"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0608108108108108	18	21	7	0	0.437444671123222	1
"889"	"Asparagine N-linked glycosylation"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"890"	"Defective ALG1 causes ALG1-CDG (CDG-1k)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"891"	"Defective ALG11 causes ALG11-CDG (CDG-1p)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"892"	"Defective ALG12 causes ALG12-CDG (CDG-1g)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"893"	"Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"894"	"Defective ALG2 causes ALG2-CDG (CDG-1i)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"895"	"Defective ALG3 causes ALG3-CDG (CDG-1d)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"896"	"Defective ALG6 causes ALG6-CDG (CDG-1c)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"897"	"Defective ALG8 causes ALG8-CDG (CDG-1h)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"898"	"Defective ALG9 causes ALG9-CDG (CDG-1l)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"899"	"Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"900"	"Defective MAN1B1 causes MRT15"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"901"	"Defective MGAT2 causes MGAT2-CDG (CDG-2a)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"902"	"Defective MOGS causes MOGS-CDG (CDG-2b)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"903"	"Defective MPDU1 causes MPDU1-CDG (CDG-1f)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"904"	"Defective RFT1 causes RFT1-CDG (CDG-1n)"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"905"	"Diseases associated with N-glycosylation of proteins"	118	118	1	0.00847457627118644	118	118	103	0.872881355932203	0.597972972972973	177	564	56	0	0.437587246741039	1
"755"	"Epigenetic regulation of gene expression"	94	94	4	0.0425531914893617	94	94	82	0.872340425531915	0.52027027027027	154	353	55	0	0.441219500910607	1
"87"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	86	86	34	0.395348837209302	86	86	75	0.872093023255814	0.493243243243243	146	396	19	0	0.442429860920648	1
"429"	"Transcriptional regulation of white adipocyte differentiation"	78	78	12	0.153846153846154	78	78	68	0.871794871794872	0.591216216216216	175	464	60	0	0.443627973688599	1
"308"	"DCC mediated attractive signaling"	14	14	3	0.214285714285714	14	14	12	0.857142857142857	0.307432432432432	91	117	34	0	0.445723450624793	1
"446"	"Regulation of IFNG signaling"	14	14	2	0.142857142857143	14	14	12	0.857142857142857	0.226351351351351	67	83	18	0	0.445723450624793	1
"447"	"Removal of the Flap Intermediate"	14	14	2	0.142857142857143	14	14	12	0.857142857142857	0.216216216216216	64	91	23	0	0.445723450624793	1
"666"	"repression of WNT target genes"	14	14	1	0.0714285714285714	14	14	12	0.857142857142857	0.0777027027027027	23	32	8	0	0.445723450624793	1
"857"	"Golgi Associated Vesicle Biogenesis"	54	54	1	0.0185185185185185	54	54	47	0.87037037037037	0.486486486486487	144	272	51	0	0.446976479835815	1
"659"	"Interferon Signaling"	196	196	15	0.076530612244898	196	196	171	0.872448979591837	0.665540540540541	197	1076	55	0	0.447867931261561	1
"16"	"SHC1 events in EGFR signaling"	22	22	12	0.545454545454545	22	22	19	0.863636363636364	0.307432432432432	91	119	32	0	0.448247695818193	1
"619"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	22	22	2	0.0909090909090909	22	22	19	0.863636363636364	0.398648648648649	118	167	58	0	0.448247695818193	1
"744"	"Intrinsic Pathway"	22	22	1	0.0454545454545455	22	22	19	0.863636363636364	0.375	111	236	56	0	0.448247695818193	1
"593"	"Activation of the pre-replicative complex"	30	30	3	0.1	30	30	26	0.866666666666667	0.331081081081081	98	172	18	0	0.448831674893077	1
"789"	"Glucagon-type ligand receptors"	30	30	1	0.0333333333333333	30	30	26	0.866666666666667	0.388513513513513	115	196	59	0	0.448831674893077	1
"790"	"Lipoprotein metabolism"	30	30	1	0.0333333333333333	30	30	26	0.866666666666667	0.185810810810811	55	103	11	0	0.448831674893077	1
"791"	"Molecules associated with elastic fibres"	30	30	1	0.0333333333333333	30	30	26	0.866666666666667	0.260135135135135	77	114	12	0	0.448831674893077	1
"793"	"Tight junction interactions"	30	30	1	0.0333333333333333	30	30	26	0.866666666666667	0.402027027027027	119	370	57	0	0.448831674893077	1
"100"	"Signaling by Interleukins"	109	109	41	0.376146788990826	109	109	95	0.871559633027523	0.692567567567568	205	692	60	0	0.453321211662112	1
"777"	"Meiosis"	85	85	3	0.0352941176470588	85	85	74	0.870588235294118	0.476351351351351	141	407	35	0	0.458866811016763	1
"713"	"Negative epigenetic regulation of rRNA expression"	77	77	4	0.051948051948052	77	77	67	0.87012987012987	0.493243243243243	146	288	55	0	0.460890738213785	1
"623"	"Assembly of the primary cilium"	179	179	16	0.0893854748603352	179	179	156	0.871508379888268	0.672297297297297	199	1007	51	0	0.462466084235425	1
"611"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	53	53	5	0.0943396226415094	53	53	46	0.867924528301887	0.625	185	366	60	0	0.46774495500246	1
"795"	"Diseases associated with visual transduction"	92	92	3	0.0326086956521739	92	92	80	0.869565217391304	0.483108108108108	143	469	30	0	0.472845988786836	1
"796"	"Visual phototransduction"	92	92	3	0.0326086956521739	92	92	80	0.869565217391304	0.483108108108108	143	469	30	0	0.472845988786836	1
"485"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	37	37	5	0.135135135135135	37	37	32	0.864864864864865	0.452702702702703	134	224	60	0	0.473368365864248	1
"782"	"PIWI-interacting RNA (piRNA) biogenesis"	29	29	1	0.0344827586206897	29	29	25	0.862068965517241	0.39527027027027	117	189	55	0	0.476777194060004	1
"783"	"RNA Polymerase I Promoter Escape"	29	29	1	0.0344827586206897	29	29	25	0.862068965517241	0.368243243243243	109	144	55	0	0.476777194060004	1
"14"	"GRB2 events in EGFR signaling"	21	21	12	0.571428571428571	21	21	18	0.857142857142857	0.307432432432432	91	114	32	0	0.480965458218525	1
"360"	"RIP-mediated NFkB activation via ZBP1"	21	21	4	0.19047619047619	21	21	18	0.857142857142857	0.22972972972973	68	90	12	0	0.480965458218525	1
"49"	"p38MAPK events"	13	13	6	0.461538461538462	13	13	11	0.846153846153846	0.125	37	43	9	0	0.48698334417646	1
"421"	"Advanced glycosylation endproduct receptor signaling"	13	13	2	0.153846153846154	13	13	11	0.846153846153846	0.131756756756757	39	45	7	0	0.48698334417646	1
"428"	"Resolution of AP sites via the single-nucleotide replacement pathway"	13	13	2	0.153846153846154	13	13	11	0.846153846153846	0.131756756756757	39	46	14	0	0.48698334417646	1
"650"	"Caspase-8 activation by cleavage"	13	13	1	0.0769230769230769	13	13	11	0.846153846153846	0.452702702702703	134	195	85	0	0.48698334417646	1
"699"	"Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)"	441	441	25	0.0566893424036281	441	441	384	0.870748299319728	0.766891891891892	227	2316	59	0	0.491779790199341	1
"700"	"GPCR ligand binding"	441	441	25	0.0566893424036281	441	441	384	0.870748299319728	0.766891891891892	227	2316	59	0	0.491779790199341	1
"520"	"p75 NTR receptor-mediated signalling"	83	83	10	0.120481927710843	83	83	72	0.867469879518072	0.543918918918919	161	478	57	0	0.492340504747421	1
"57"	"Signalling to ERKs"	44	44	19	0.431818181818182	44	44	38	0.863636363636364	0.331081081081081	98	182	18	0	0.493376242448034	1
"69"	"TRAF6 Mediated Induction of proinflammatory cytokines"	75	75	31	0.413333333333333	75	75	65	0.866666666666667	0.47972972972973	142	328	18	0	0.496088978197404	1
"882"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	106	106	1	0.00943396226415094	106	106	92	0.867924528301887	0.577702702702703	171	543	55	0	0.497777546765297	1
"883"	"Nonsense-Mediated Decay (NMD)"	106	106	1	0.00943396226415094	106	106	92	0.867924528301887	0.577702702702703	171	543	55	0	0.497777546765297	1
"11"	"G2/M DNA replication checkpoint"	5	5	3	0.6	5	5	4	0.8	0.0168918918918919	5	5	2	0	0.502100099636619	1
"77"	"Activation of caspases through apoptosome-mediated cleavage"	5	5	2	0.4	5	5	4	0.8	0.0540540540540541	16	16	8	0	0.502100099636619	1
"79"	"Cytochrome c-mediated apoptotic response"	5	5	2	0.4	5	5	4	0.8	0.0540540540540541	16	16	8	0	0.502100099636619	1
"337"	"Cyclin B2 mediated events"	5	5	1	0.2	5	5	4	0.8	0.0202702702702703	6	6	2	0	0.502100099636619	1
"341"	"Nicotinamide salvaging"	5	5	1	0.2	5	5	4	0.8	0.0574324324324324	17	18	10	0	0.502100099636619	1
"344"	"SMAC binds to IAPs"	5	5	1	0.2	5	5	4	0.8	0.0574324324324324	17	19	8	0	0.502100099636619	1
"345"	"SMAC-mediated apoptotic response"	5	5	1	0.2	5	5	4	0.8	0.0574324324324324	17	19	8	0	0.502100099636619	1
"346"	"SMAC-mediated dissociation of IAP:caspase complexes"	5	5	1	0.2	5	5	4	0.8	0.0574324324324324	17	19	8	0	0.502100099636619	1
"62"	"SHC1 events in ERBB4 signaling"	28	28	12	0.428571428571429	28	28	24	0.857142857142857	0.266891891891892	79	110	18	0	0.505530982553162	1
"772"	"Dual incision reaction in TC-NER"	28	28	1	0.0357142857142857	28	28	24	0.857142857142857	0.341216216216216	101	145	55	0	0.505530982553162	1
"773"	"Formation of transcription-coupled NER (TC-NER) repair complex"	28	28	1	0.0357142857142857	28	28	24	0.857142857142857	0.341216216216216	101	145	55	0	0.505530982553162	1
"707"	"NoRC negatively regulates rRNA expression"	74	74	4	0.0540540540540541	74	74	64	0.864864864864865	0.462837837837838	137	272	55	0	0.513966374178485	1
"430"	"Base Excision Repair"	20	20	3	0.15	20	20	17	0.85	0.22972972972973	68	93	23	0	0.514937647039172	1
"431"	"Resolution of Abasic Sites (AP sites)"	20	20	3	0.15	20	20	17	0.85	0.22972972972973	68	93	23	0	0.514937647039172	1
"432"	"Syndecan interactions"	20	20	3	0.15	20	20	17	0.85	0.243243243243243	72	88	13	0	0.514937647039172	1
"720"	"Fatty Acyl-CoA Biosynthesis"	20	20	1	0.05	20	20	17	0.85	0.192567567567568	57	69	11	0	0.514937647039172	1
"885"	"Cap-dependent Translation Initiation"	112	112	1	0.00892857142857143	112	112	97	0.866071428571429	0.641891891891892	190	692	60	0	0.52359888573129	1
"886"	"Eukaryotic Translation Initiation"	112	112	1	0.00892857142857143	112	112	97	0.866071428571429	0.641891891891892	190	692	60	0	0.52359888573129	1
"50"	"Post NMDA receptor activation events"	35	35	16	0.457142857142857	35	35	30	0.857142857142857	0.334459459459459	99	144	31	0	0.524637992855489	1
"5"	"ERK activation"	12	12	9	0.75	12	12	10	0.833333333333333	0.165540540540541	49	54	18	0	0.530692228095611	1
"390"	"Bile salt and organic anion SLC transporters"	12	12	2	0.166666666666667	12	12	10	0.833333333333333	0.0743243243243243	22	30	7	0	0.530692228095611	1
"635"	"Caspase-mediated cleavage of cytoskeletal proteins"	12	12	1	0.0833333333333333	12	12	10	0.833333333333333	0.199324324324324	59	71	32	0	0.530692228095611	1
"638"	"Miscellaneous substrates"	12	12	1	0.0833333333333333	12	12	10	0.833333333333333	0.097972972972973	29	44	19	0	0.530692228095611	1
"640"	"Vitamin B5 (pantothenate) metabolism"	12	12	1	0.0833333333333333	12	12	10	0.833333333333333	0.0844594594594595	25	28	8	0	0.530692228095611	1
"703"	"Antiviral mechanism by IFN-stimulated genes"	73	73	4	0.0547945205479452	73	73	63	0.863013698630137	0.52027027027027	154	386	55	0	0.531987401273002	1
"704"	"ISG15 antiviral mechanism"	73	73	4	0.0547945205479452	73	73	63	0.863013698630137	0.52027027027027	154	386	55	0	0.531987401273002	1
"53"	"CREB phosphorylation through the activation of Ras"	27	27	12	0.444444444444444	27	27	23	0.851851851851852	0.243243243243243	72	96	17	0	0.53499392782452	1
"55"	"Prolonged ERK activation events"	27	27	12	0.444444444444444	27	27	23	0.851851851851852	0.277027027027027	82	127	18	0	0.53499392782452	1
"179"	"Recycling pathway of L1"	27	27	8	0.296296296296296	27	27	23	0.851851851851852	0.415540540540541	123	177	58	0	0.53499392782452	1
"295"	"Sema4D in semaphorin signaling"	27	27	6	0.222222222222222	27	27	23	0.851851851851852	0.216216216216216	64	83	16	0	0.53499392782452	1
"726"	"Formation of HIV elongation complex in the absence of HIV Tat"	42	42	2	0.0476190476190476	42	42	36	0.857142857142857	0.408783783783784	121	262	55	0	0.540436738227791	1
"728"	"Formation of RNA Pol II elongation complex"	42	42	2	0.0476190476190476	42	42	36	0.857142857142857	0.408783783783784	121	262	55	0	0.540436738227791	1
"735"	"RNA Polymerase II Transcription Elongation"	42	42	2	0.0476190476190476	42	42	36	0.857142857142857	0.408783783783784	121	262	55	0	0.540436738227791	1
"474"	"Mitotic Anaphase"	172	172	24	0.13953488372093	172	172	149	0.866279069767442	0.658783783783784	195	718	55	0	0.544350460997676	1
"288"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	49	0.859649122807018	0.506756756756757	150	345	60	0	0.545487213847161	1
"289"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	49	0.859649122807018	0.506756756756757	150	345	60	0	0.545487213847161	1
"911"	"Translation"	148	148	1	0.00675675675675676	148	148	128	0.864864864864865	0.692567567567568	205	968	60	0	0.55639447147297	1
"821"	"Elastic fibre formation"	41	41	1	0.024390243902439	41	41	35	0.853658536585366	0.297297297297297	88	141	12	0	0.564392447389881	1
"86"	"MyD88 cascade initiated on plasma membrane"	86	86	34	0.395348837209302	86	86	74	0.86046511627907	0.496621621621622	147	375	19	0	0.570936925308453	1
"88"	"Toll Like Receptor 10 (TLR10) Cascade"	86	86	34	0.395348837209302	86	86	74	0.86046511627907	0.496621621621622	147	375	19	0	0.570936925308453	1
"89"	"Toll Like Receptor 5 (TLR5) Cascade"	86	86	34	0.395348837209302	86	86	74	0.86046511627907	0.496621621621622	147	375	19	0	0.570936925308453	1
"101"	"EPH-ephrin mediated repulsion of cells"	48	48	18	0.375	48	48	41	0.854166666666667	0.435810810810811	129	329	58	0	0.576111204346401	1
"27"	"CREB phosphorylation through the activation of CaMKK"	4	4	2	0.5	4	4	3	0.75	0.0472972972972973	14	14	6	0	0.576300595926033	1
"260"	"NS1 Mediated Effects on Host Pathways"	4	4	1	0.25	4	4	3	0.75	0.0777027027027027	23	24	19	0	0.576300595926033	1
"266"	"Processing of DNA ends prior to end rejoining"	4	4	1	0.25	4	4	3	0.75	0.0912162162162162	27	27	16	0	0.576300595926033	1
"267"	"Proton/oligonucleotide cotransporters"	4	4	1	0.25	4	4	3	0.75	0.0574324324324324	17	17	9	0	0.576300595926033	1
"52"	"Purine ribonucleoside monophosphate biosynthesis"	11	11	5	0.454545454545455	11	11	9	0.818181818181818	0.195945945945946	58	71	43	0	0.576673021543171	1
"449"	"Separation of Sister Chromatids"	161	161	23	0.142857142857143	161	161	139	0.863354037267081	0.641891891891892	190	648	55	0	0.584376350411201	1
"214"	"Synthesis and interconversion of nucleotide di- and triphosphates"	18	18	5	0.277777777777778	18	18	15	0.833333333333333	0.209459459459459	62	82	16	0	0.586054617631362	1
"702"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	18	18	1	0.0555555555555556	18	18	15	0.833333333333333	0.141891891891892	42	50	15	0	0.586054617631362	1
"437"	"Circadian Clock"	55	55	8	0.145454545454545	55	55	47	0.854545454545454	0.537162162162162	159	325	60	0	0.586574276640247	1
"630"	"Phospholipid metabolism"	138	138	12	0.0869565217391304	138	138	119	0.86231884057971	0.652027027027027	193	833	60	0	0.586925159103795	1
"111"	"Toll Like Receptor 9 (TLR9) Cascade"	92	92	34	0.369565217391304	92	92	79	0.858695652173913	0.550675675675676	163	462	43	0	0.596073740793703	1
"46"	"SHC1 events in ERBB2 signaling"	32	32	15	0.46875	32	32	27	0.84375	0.35472972972973	105	152	32	0	0.604473108739799	1
"612"	"DNA strand elongation"	32	32	3	0.09375	32	32	27	0.84375	0.459459459459459	136	237	55	0	0.604473108739799	1
"215"	"Toll-Like Receptors Cascades"	144	144	40	0.277777777777778	144	144	124	0.861111111111111	0.679054054054054	201	815	85	0	0.607019108396836	1
"909"	"Processing of Capped Intron-Containing Pre-mRNA"	144	144	1	0.00694444444444444	144	144	124	0.861111111111111	0.631756756756757	187	647	55	0	0.607019108396836	1
"478"	"Mitotic Metaphase and Anaphase"	173	173	24	0.138728323699422	173	173	149	0.861271676300578	0.658783783783784	195	718	55	0	0.621336565491645	1
"44"	"activated TAK1 mediates p38 MAPK activation"	17	17	8	0.470588235294118	17	17	14	0.823529411764706	0.206081081081081	61	80	14	0	0.622806127502565	1
"279"	"Ras activation uopn Ca2+ infux through NMDA receptor"	17	17	4	0.235294117647059	17	17	14	0.823529411764706	0.165540540540541	49	58	17	0	0.622806127502565	1
"280"	"Unblocking of NMDA receptor, glutamate binding and activation"	17	17	4	0.235294117647059	17	17	14	0.823529411764706	0.179054054054054	53	65	17	0	0.622806127502565	1
"374"	"KSRP destabilizes mRNA"	17	17	3	0.176470588235294	17	17	14	0.823529411764706	0.239864864864865	71	98	32	0	0.622806127502565	1
"8"	"ERK1 activation"	10	10	7	0.7	10	10	8	0.8	0.135135135135135	40	44	18	0	0.624643126426851	1
"597"	"IRAK2 mediated activation of TAK1 complex"	10	10	1	0.1	10	10	8	0.8	0.111486486486486	33	37	14	0	0.624643126426851	1
"598"	"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"	10	10	1	0.1	10	10	8	0.8	0.111486486486486	33	37	14	0	0.624643126426851	1
"881"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	105	105	1	0.00952380952380952	105	105	90	0.857142857142857	0.60472972972973	179	579	55	0	0.626321341497903	1
"399"	"REV-ERBA represses gene expression"	24	24	4	0.166666666666667	24	24	20	0.833333333333333	0.402027027027027	119	156	60	0	0.626370505603672	1
"94"	"NOD1/2 Signaling Pathway"	31	31	12	0.387096774193548	31	31	26	0.838709677419355	0.351351351351351	104	200	24	0	0.631455513969411	1
"797"	"Elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.391891891891892	116	190	55	0	0.631455513969411	1
"798"	"HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.391891891891892	116	190	55	0	0.631455513969411	1
"799"	"Pausing and recovery of HIV elongation"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.391891891891892	116	190	55	0	0.631455513969411	1
"801"	"RNA Polymerase I Transcription Termination"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.381756756756757	113	150	55	0	0.631455513969411	1
"564"	"Collagen degradation"	38	38	4	0.105263157894737	38	38	32	0.842105263157895	0.344594594594595	102	307	25	0	0.637014838803509	1
"879"	"3' -UTR-mediated translational regulation"	104	104	1	0.00961538461538462	104	104	89	0.855769230769231	0.601351351351351	178	585	55	0	0.64083790854658	1
"880"	"L13a-mediated translational silencing of Ceruloplasmin expression"	104	104	1	0.00961538461538462	104	104	89	0.855769230769231	0.601351351351351	178	585	55	0	0.64083790854658	1
"661"	"Interferon alpha/beta signaling"	67	67	5	0.0746268656716418	67	67	57	0.850746268656716	0.314189189189189	93	470	26	0	0.641137498063976	1
"420"	"Anchoring of the basal body to the plasma membrane"	89	89	14	0.157303370786517	89	89	76	0.853932584269663	0.533783783783784	158	445	32	0	0.643325693662257	1
"648"	"Degradation of the extracellular matrix"	89	89	7	0.0786516853932584	89	89	76	0.853932584269663	0.513513513513513	152	535	25	0	0.643325693662257	1
"873"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	89	89	1	0.0112359550561798	89	89	76	0.853932584269663	0.550675675675676	163	484	55	0	0.643325693662257	1
"24"	"ARMS-mediated activation"	23	23	12	0.521739130434783	23	23	19	0.826086956521739	0.236486486486486	70	101	18	0	0.657307704742381	1
"751"	"BBSome-mediated cargo-targeting to cilium"	23	23	1	0.0434782608695652	23	23	19	0.826086956521739	0.283783783783784	84	125	20	0	0.657307704742381	1
"47"	"GRB2 events in ERBB2 signaling"	30	30	14	0.466666666666667	30	30	25	0.833333333333333	0.35472972972973	105	145	32	0	0.658423068645035	1
"394"	"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity"	30	30	5	0.166666666666667	30	30	25	0.833333333333333	0.347972972972973	103	196	58	0	0.658423068645035	1
"406"	"Trafficking of AMPA receptors"	30	30	5	0.166666666666667	30	30	25	0.833333333333333	0.347972972972973	103	196	58	0	0.658423068645035	1
"599"	"Inactivation, recovery and regulation of the phototransduction cascade"	30	30	3	0.1	30	30	25	0.833333333333333	0.300675675675676	89	136	18	0	0.658423068645035	1
"670"	"HSF1 activation"	30	30	2	0.0666666666666667	30	30	25	0.833333333333333	0.425675675675676	126	213	33	0	0.658423068645035	1
"832"	"Glycerophospholipid biosynthesis"	88	88	2	0.0227272727272727	88	88	75	0.852272727272727	0.597972972972973	177	529	56	0	0.658883548732736	1
"810"	"Integrin cell surface interactions"	66	66	2	0.0303030303030303	66	66	56	0.848484848484849	0.331081081081081	98	206	11	0	0.659139733576918	1
"30"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	16	16	8	0.5	16	16	13	0.8125	0.202702702702703	60	78	14	0	0.660018680739767	1
"268"	"Rap1 signalling"	16	16	4	0.25	16	16	13	0.8125	0.206081081081081	61	86	16	0	0.660018680739767	1
"363"	"Processive synthesis on the lagging strand"	16	16	3	0.1875	16	16	13	0.8125	0.233108108108108	69	96	23	0	0.660018680739767	1
"683"	"Mismatch Repair"	16	16	1	0.0625	16	16	13	0.8125	0.179054054054054	53	74	23	0	0.660018680739767	1
"688"	"Trafficking of GluR2-containing AMPA receptors"	16	16	1	0.0625	16	16	13	0.8125	0.300675675675676	89	105	58	0	0.660018680739767	1
"10"	"Formation of apoptosome"	3	3	2	0.666666666666667	3	3	2	0.666666666666667	0.0202702702702703	6	6	4	0	0.661453648167887	1
"138"	"Activation of BMF and translocation to mitochondria"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0135135135135135	4	4	3	0	0.661453648167887	1
"143"	"Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0202702702702703	6	6	4	0	0.661453648167887	1
"146"	"TNF signaling"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0371621621621622	11	11	6	0	0.661453648167887	1
"148"	"The NLRP1 inflammasome"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0878378378378378	26	26	13	0	0.661453648167887	1
"150"	"betaKlotho-mediated ligand binding"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.273648648648649	81	82	81	0	0.661453648167887	1
"168"	"Costimulation by the CD28 family"	73	73	22	0.301369863013699	73	73	62	0.849315068493151	0.547297297297297	162	476	60	0	0.664343718581581	1
"56"	"Pyrimidine salvage reactions"	9	9	4	0.444444444444444	9	9	7	0.777777777777778	0.0675675675675676	20	25	8	0	0.674187193944796	1
"145"	"Regulation of gene expression by Hypoxia-inducible Factor"	9	9	3	0.333333333333333	9	9	7	0.777777777777778	0.168918918918919	50	56	19	0	0.674187193944796	1
"741"	"Chromosome Maintenance"	87	87	4	0.0459770114942529	87	87	74	0.850574712643678	0.516891891891892	153	401	55	0	0.674300377528929	1
"884"	"SRP-dependent cotranslational protein targeting to membrane"	109	109	1	0.00917431192660551	109	109	93	0.853211009174312	0.594594594594595	176	555	53	0	0.67458484304166	1
"876"	"Formation of a pool of free 40S subunits"	94	94	1	0.0106382978723404	94	94	80	0.851063829787234	0.557432432432432	165	421	53	0	0.679062487350116	1
"321"	"FBXW7 Mutants and NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"326"	"Signaling by NOTCH1"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"327"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"328"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"329"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"330"	"Signaling by NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"331"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	72	72	15	0.208333333333333	72	72	61	0.847222222222222	0.554054054054054	164	412	60	0	0.681199192411745	1
"480"	"Extension of Telomeres"	29	29	4	0.137931034482759	29	29	24	0.827586206896552	0.439189189189189	130	215	55	0	0.685242160635397	1
"476"	"Transcriptional activation of mitochondrial biogenesis"	43	43	6	0.13953488372093	43	43	36	0.837209302325581	0.469594594594595	139	234	60	0	0.6865605665085	1
"759"	"IRE1alpha activates chaperones"	50	50	2	0.04	50	50	42	0.84	0.462837837837838	137	339	56	0	0.688809436112291	1
"824"	"Collagen formation"	86	86	2	0.0232558139534884	86	86	73	0.848837209302326	0.537162162162162	159	599	37	0	0.689549434358414	1
"912"	"Diseases of glycosylation"	226	226	1	0.00442477876106195	226	226	194	0.858407079646018	0.692567567567568	205	1079	60	0	0.693281024647068	1
"908"	"Post-translational protein modification"	278	278	2	0.00719424460431655	278	278	239	0.859712230215827	0.733108108108108	217	1689	60	0	0.695997466717245	1
"137"	"Activation of BAD and translocation to mitochondria"	15	15	5	0.333333333333333	15	15	12	0.8	0.222972972972973	66	82	15	0	0.697383342251013	1
"245"	"CREB phosphorylation through the activation of CaMKII"	15	15	4	0.266666666666667	15	15	12	0.8	0.162162162162162	48	56	17	0	0.697383342251013	1
"488"	"Prolactin receptor signaling"	15	15	2	0.133333333333333	15	15	12	0.8	0.179054054054054	53	74	18	0	0.697383342251013	1
"671"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	15	15	1	0.0666666666666667	15	15	12	0.8	0.179054054054054	53	71	23	0	0.697383342251013	1
"672"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	15	15	1	0.0666666666666667	15	15	12	0.8	0.175675675675676	52	72	23	0	0.697383342251013	1
"523"	"Non-integrin membrane-ECM interactions"	42	42	5	0.119047619047619	42	42	35	0.833333333333333	0.361486486486487	107	182	13	0	0.70812670236242	1
"737"	"Transcriptional regulation of pluripotent stem cells"	42	42	2	0.0476190476190476	42	42	35	0.833333333333333	0.432432432432432	128	275	60	0	0.70812670236242	1
"365"	"Host Interactions of HIV factors"	135	135	25	0.185185185185185	135	135	115	0.851851851851852	0.635135135135135	188	701	58	0	0.716707260098072	1
"887"	"mRNA Splicing"	113	113	1	0.00884955752212389	113	113	96	0.849557522123894	0.587837837837838	174	521	55	0	0.718272362682226	1
"888"	"mRNA Splicing - Major Pathway"	113	113	1	0.00884955752212389	113	113	96	0.849557522123894	0.587837837837838	174	521	55	0	0.718272362682226	1
"442"	"Lagging Strand Synthesis"	21	21	3	0.142857142857143	21	21	17	0.80952380952381	0.371621621621622	110	159	55	0	0.718770779963059	1
"867"	"Eukaryotic Translation Termination"	84	84	1	0.0119047619047619	84	84	71	0.845238095238095	0.537162162162162	159	358	53	0	0.719438473150494	1
"868"	"Peptide chain elongation"	84	84	1	0.0119047619047619	84	84	71	0.845238095238095	0.52027027027027	154	349	53	0	0.719438473150494	1
"108"	"WNT mediated activation of DVL"	8	8	3	0.375	8	8	6	0.75	0.222972972972973	66	73	60	0	0.724724165087595	1
"261"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	8	8	2	0.25	8	8	6	0.75	0.131756756756757	39	54	13	0	0.724724165087595	1
"501"	"Host Interactions with Influenza Factors"	8	8	1	0.125	8	8	6	0.75	0.158783783783784	47	59	19	0	0.724724165087595	1
"505"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	8	8	1	0.125	8	8	6	0.75	0.111486486486486	33	34	19	0	0.724724165087595	1
"506"	"Release of Hh-Np from the secreting cell"	8	8	1	0.125	8	8	6	0.75	0.0574324324324324	17	19	5	0	0.724724165087595	1
"845"	"XBP1(S) activates chaperone genes"	48	48	1	0.0208333333333333	48	48	40	0.833333333333333	0.452702702702703	134	331	56	0	0.728264959693252	1
"436"	"Signaling by Retinoic Acid"	41	41	6	0.146341463414634	41	41	34	0.829268292682927	0.368243243243243	109	228	41	0	0.729336958312404	1
"708"	"Extracellular matrix organization"	266	266	14	0.0526315789473684	266	266	228	0.857142857142857	0.692567567567568	205	1352	37	0	0.733299720660794	1
"854"	"RNA Polymerase II Transcription"	104	104	2	0.0192307692307692	104	104	88	0.846153846153846	0.591216216216216	175	516	55	0	0.740776506267974	1
"861"	"Clathrin derived vesicle budding"	61	61	1	0.0163934426229508	61	61	51	0.836065573770492	0.496621621621622	147	297	51	0	0.745876367797965	1
"862"	"trans-Golgi Network Vesicle Budding"	61	61	1	0.0163934426229508	61	61	51	0.836065573770492	0.496621621621622	147	297	51	0	0.745876367797965	1
"719"	"Dual incision reaction in GG-NER"	20	20	1	0.05	20	20	16	0.8	0.125	37	49	6	0	0.748860140206196	1
"721"	"Formation of incision complex in GG-NER"	20	20	1	0.05	20	20	16	0.8	0.125	37	49	6	0	0.748860140206196	1
"804"	"Membrane Trafficking"	190	190	6	0.0315789473684211	190	190	162	0.852631578947368	0.699324324324324	207	876	58	0	0.752813645593167	1
"222"	"Synthesis of PIPs at the plasma membrane"	33	33	9	0.272727272727273	33	33	27	0.818181818181818	0.371621621621622	110	205	60	0	0.754958161977742	1
"622"	"deactivation of the beta-catenin transactivating complex"	33	33	3	0.0909090909090909	33	33	27	0.818181818181818	0.331081081081081	98	141	30	0	0.754958161977742	1
"2"	"Signalling to ERK5"	2	2	2	1	2	2	1	0.5	0.00675675675675676	2	2	2	0	0.759174045715784	1
"28"	"Inhibition of PKR"	2	2	1	0.5	2	2	1	0.5	0.00675675675675676	2	2	2	0	0.759174045715784	1
"29"	"Inhibition of Signaling by Overexpressed EGFR"	2	2	1	0.5	2	2	1	0.5	0.108108108108108	32	32	32	0	0.759174045715784	1
"32"	"Mitotic Metaphase/Anaphase Transition"	2	2	1	0.5	2	2	1	0.5	0.00675675675675676	2	2	2	0	0.759174045715784	1
"36"	"Resolution of D-loop structures"	2	2	1	0.5	2	2	1	0.5	0.0168918918918919	5	5	5	0	0.759174045715784	1
"37"	"Resolution of D-loop structures through Holliday junction intermediates"	2	2	1	0.5	2	2	1	0.5	0.0168918918918919	5	5	5	0	0.759174045715784	1
"286"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	26	26	6	0.230769230769231	26	26	21	0.807692307692308	0.293918918918919	87	126	14	0	0.76336779778942	1
"653"	"EGFR downregulation"	26	26	2	0.0769230769230769	26	26	21	0.807692307692308	0.442567567567568	131	172	58	0	0.76336779778942	1
"164"	"Signal regulatory protein (SIRP) family interactions"	13	13	4	0.307692307692308	13	13	10	0.769230769230769	0.256756756756757	76	85	34	0	0.771091089650943	1
"651"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production"	13	13	1	0.0769230769230769	13	13	10	0.769230769230769	0.219594594594595	65	80	43	0	0.771091089650943	1
"656"	"Retrograde neurotrophin signalling"	13	13	1	0.0769230769230769	13	13	10	0.769230769230769	0.304054054054054	90	112	58	0	0.771091089650943	1
"657"	"Trafficking and processing of endosomal TLR"	13	13	1	0.0769230769230769	13	13	10	0.769230769230769	0.226351351351351	67	96	22	0	0.771091089650943	1
"192"	"Apoptotic factor-mediated response"	7	7	2	0.285714285714286	7	7	5	0.714285714285714	0.0709459459459459	21	23	8	0	0.775467491091488	1
"441"	"Interleukin-1 processing"	7	7	1	0.142857142857143	7	7	5	0.714285714285714	0.0945945945945946	28	36	12	0	0.775467491091488	1
"448"	"Scavenging by Class F Receptors"	7	7	1	0.142857142857143	7	7	5	0.714285714285714	0.0574324324324324	17	18	7	0	0.775467491091488	1
"866"	"Influenza Life Cycle"	143	143	2	0.013986013986014	143	143	121	0.846153846153846	0.635135135135135	188	640	55	0	0.786125953272375	1
"206"	"Activation of BH3-only proteins"	25	25	7	0.28	25	25	20	0.8	0.307432432432432	91	125	15	0	0.788128906884467	1
"521"	"Cellular response to hypoxia"	25	25	3	0.12	25	25	20	0.8	0.253378378378378	75	100	19	0	0.788128906884467	1
"522"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	25	25	3	0.12	25	25	20	0.8	0.253378378378378	75	100	19	0	0.788128906884467	1
"276"	"Intrinsic Pathway for Apoptosis"	38	38	9	0.236842105263158	38	38	31	0.815789473684211	0.361486486486487	107	180	15	0	0.790043375258675	1
"808"	"Transcription of the HIV genome"	65	65	2	0.0307692307692308	65	65	54	0.830769230769231	0.503378378378378	149	377	55	0	0.791606707179653	1
"865"	"Influenza Viral RNA Transcription and Replication"	135	135	2	0.0148148148148148	135	135	114	0.844444444444444	0.611486486486487	181	598	55	0	0.794487838598352	1
"307"	"Cellular response to heat stress"	51	51	11	0.215686274509804	51	51	42	0.823529411764706	0.496621621621622	147	300	35	0	0.797161479709947	1
"850"	"Cargo trafficking to the periciliary membrane"	51	51	1	0.0196078431372549	51	51	42	0.823529411764706	0.439189189189189	130	289	31	0	0.797161479709947	1
"604"	"The phototransduction cascade"	31	31	3	0.0967741935483871	31	31	25	0.806451612903226	0.300675675675676	89	136	18	0	0.798654352958278	1
"848"	"Influenza Infection"	148	148	3	0.0202702702702703	148	148	125	0.844594594594595	0.64527027027027	191	682	55	0	0.806426667913903	1
"13"	"Serotonin receptors"	12	12	7	0.583333333333333	12	12	9	0.75	0.0810810810810811	24	31	8	0	0.806576988780966	1
"639"	"Processive synthesis on the C-strand of the telomere"	12	12	1	0.0833333333333333	12	12	9	0.75	0.162162162162162	48	60	23	0	0.806576988780966	1
"760"	"Nucleotide Excision Repair"	50	50	2	0.04	50	50	41	0.82	0.452702702702703	134	288	55	0	0.813134673362757	1
"825"	"HIV Transcription Initiation"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"827"	"RNA Polymerase II HIV Promoter Escape"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"828"	"RNA Polymerase II Promoter Escape"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"829"	"RNA Polymerase II Transcription Initiation"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"830"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"831"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	43	43	1	0.0232558139534884	43	43	35	0.813953488372093	0.412162162162162	122	226	55	0	0.819038258182579	1
"403"	"Synthesis of 15-eicosatetraenoic acid derivatives"	6	6	1	0.166666666666667	6	6	4	0.666666666666667	0.0472972972972973	14	15	5	0	0.825377242203599	1
"814"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	36	36	1	0.0277777777777778	36	36	29	0.805555555555556	0.39527027027027	117	266	56	0	0.827316492394737	1
"802"	"RNA Polymerase II Pre-transcription Events"	62	62	2	0.032258064516129	62	62	51	0.82258064516129	0.486486486486487	144	365	55	0	0.833093170464966	1
"493"	"Telomere C-strand (Lagging Strand) Synthesis"	23	23	3	0.130434782608696	23	23	18	0.782608695652174	0.381756756756757	113	164	55	0	0.834811634642303	1
"872"	"Eukaryotic Translation Elongation"	89	89	1	0.0112359550561798	89	89	74	0.831460674157303	0.523648648648649	155	392	53	0	0.835063929117651	1
"15"	"DSCAM interactions"	11	11	6	0.545454545454545	11	11	8	0.727272727272727	0.128378378378378	38	44	17	0	0.840508598403412	1
"370"	"Recruitment of NuMA to mitotic centrosomes"	11	11	2	0.181818181818182	11	11	8	0.727272727272727	0.162162162162162	48	56	34	0	0.840508598403412	1
"539"	"Regulation of HSF1-mediated heat shock response"	35	35	4	0.114285714285714	35	35	28	0.8	0.425675675675676	126	241	35	0	0.844782296525333	1
"667"	"Class A/1 (Rhodopsin-like receptors)"	314	314	22	0.0700636942675159	314	314	267	0.85031847133758	0.746621621621622	221	1652	58	0	0.85253974816269	1
"689"	"Metabolic disorders of biological oxidation enzymes"	614	614	38	0.0618892508143322	614	614	526	0.856677524429967	0.807432432432432	239	3108	59	0	0.856615332816843	1
"682"	"Cell-extracellular matrix interactions"	16	16	1	0.0625	16	16	12	0.75	0.165540540540541	49	58	19	0	0.859296875466412	1
"696"	"Global Genomic NER (GG-NER)"	34	34	2	0.0588235294117647	34	34	27	0.794117647058823	0.381756756756757	113	165	55	0	0.861385041890099	1
"738"	"Peptide ligand-binding receptors"	190	190	9	0.0473684210526316	190	190	160	0.842105263157895	0.692567567567568	205	942	58	0	0.865120741746194	1
"155"	"Interleukin-1 signaling"	40	40	13	0.325	40	40	32	0.8	0.47972972972973	142	216	53	0	0.865890099893404	1
"25"	"Abacavir transport and metabolism"	10	10	5	0.5	10	10	7	0.7	0.0709459459459459	21	23	13	0	0.872363464016577	1
"76"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	10	10	4	0.4	10	10	7	0.7	0.0743243243243243	22	25	6	0	0.872363464016577	1
"172"	"Netrin mediated repulsion signals"	10	10	3	0.3	10	10	7	0.7	0.202702702702703	60	69	34	0	0.872363464016577	1
"340"	"Nef Mediated CD4 Down-regulation"	10	10	2	0.2	10	10	7	0.7	0.260135135135135	77	85	58	0	0.872363464016577	1
"602"	"Regulated proteolysis of p75NTR"	10	10	1	0.1	10	10	7	0.7	0.10472972972973	31	44	12	0	0.872363464016577	1
"357"	"Mitochondrial biogenesis"	52	52	10	0.192307692307692	52	52	42	0.807692307692308	0.47972972972973	142	257	60	0	0.876057396063948	1
"677"	"WNT5A-dependent internalization of FZD4"	15	15	1	0.0666666666666667	15	15	11	0.733333333333333	0.293918918918919	87	96	58	0	0.883180158428273	1
"749"	"Transcription-coupled NER (TC-NER)"	45	45	2	0.0444444444444444	45	45	36	0.8	0.429054054054054	127	267	55	0	0.883619836059365	1
"514"	"HIV Infection"	227	227	28	0.123348017621145	227	227	191	0.841409691629956	0.712837837837838	211	1221	58	0	0.894990014963453	1
"293"	"Formyl peptide receptors bind formyl peptides and many other ligands"	9	9	2	0.222222222222222	9	9	6	0.666666666666667	0.0304054054054054	9	11	4	0	0.901603564087391	1
"678"	"Mitotic Prometaphase"	108	108	7	0.0648148148148148	108	108	89	0.824074074074074	0.567567567567568	168	447	43	0	0.904984949084323	1
"63"	"Uptake and function of anthrax toxins"	14	14	6	0.428571428571429	14	14	10	0.714285714285714	0.0743243243243243	22	27	6	0	0.905101831587362	1
"665"	"Mitotic Telophase/Cytokinesis"	14	14	1	0.0714285714285714	14	14	10	0.714285714285714	0.27027027027027	80	94	28	0	0.905101831587362	1
"819"	"Unfolded Protein Response (UPR)"	81	81	2	0.0246913580246914	81	81	66	0.814814814814815	0.584459459459459	173	483	56	0	0.908799408534289	1
"786"	"Activated NOTCH1 Transmits Signal to the Nucleus"	30	30	1	0.0333333333333333	30	30	23	0.766666666666667	0.260135135135135	77	118	15	0	0.918214046529035	1
"366"	"Cytochrome P450 - arranged by substrate type"	60	60	11	0.183333333333333	60	60	48	0.8	0.341216216216216	101	311	33	0	0.922518403008418	1
"875"	"Viral mRNA Translation"	92	92	1	0.0108695652173913	92	92	75	0.815217391304348	0.554054054054054	164	373	53	0	0.923075490471583	1
"381"	"CDO in myogenesis"	29	29	5	0.172413793103448	29	29	22	0.758620689655172	0.182432432432432	54	76	10	0	0.92986552756969	1
"383"	"Myogenesis"	29	29	5	0.172413793103448	29	29	22	0.758620689655172	0.182432432432432	54	76	10	0	0.92986552756969	1
"491"	"Double-Strand Break Repair"	23	23	3	0.130434782608696	23	23	17	0.739130434782609	0.212837837837838	63	97	16	0	0.934295212546099	1
"249"	"Signaling by the B Cell Receptor (BCR)"	209	209	55	0.263157894736842	209	209	174	0.832535885167464	0.777027027027027	230	1296	82	0	0.940691155503483	1
"528"	"Homologous Recombination Repair"	17	17	2	0.117647058823529	17	17	12	0.705882352941177	0.162162162162162	48	65	12	0	0.942560617563785	1
"529"	"Homologous recombination repair of replication-independent double-strand breaks"	17	17	2	0.117647058823529	17	17	12	0.705882352941177	0.162162162162162	48	65	12	0	0.942560617563785	1
"694"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	17	17	1	0.0588235294117647	17	17	12	0.705882352941177	0.317567567567568	94	122	55	0	0.942560617563785	1
"695"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	17	17	1	0.0588235294117647	17	17	12	0.705882352941177	0.317567567567568	94	122	55	0	0.942560617563785	1
"496"	"Immune System"	1216	1216	153	0.125822368421053	1216	1216	1042	0.856907894736842	0.89527027027027	265	6803	85	0	0.942752788170399	1
"425"	"Nuclear signaling by ERBB4"	39	39	6	0.153846153846154	39	39	30	0.769230769230769	0.327702702702703	97	180	24	0	0.944546565615537	1
"722"	"Resolution of Sister Chromatid Cohesion"	100	100	5	0.05	100	100	81	0.81	0.540540540540541	160	378	28	0	0.949357828990515	1
"440"	"Homologous DNA pairing and strand exchange"	7	7	1	0.142857142857143	7	7	4	0.571428571428571	0.0675675675675676	20	20	12	0	0.950151619983878	1
"645"	"Arachidonic acid metabolism"	50	50	4	0.08	50	50	39	0.78	0.212837837837838	63	132	8	0	0.950271929883876	1
"606"	"Aflatoxin activation and detoxification"	21	21	2	0.0952380952380952	21	21	15	0.714285714285714	0.226351351351351	67	108	22	0	0.95593168794728	1
"607"	"Defective ACY1 causes encephalopathy"	21	21	2	0.0952380952380952	21	21	15	0.714285714285714	0.226351351351351	67	108	22	0	0.95593168794728	1
"367"	"CYP2E1 reactions"	11	11	2	0.181818181818182	11	11	7	0.636363636363636	0.0135135135135135	4	12	2	0	0.957309772318351	1
"225"	"Generation of second messenger molecules"	37	37	10	0.27027027027027	37	37	28	0.756756756756757	0.378378378378378	112	225	51	0	0.958940783158475	1
"608"	"Netrin-1 signaling"	42	42	4	0.0952380952380952	42	42	32	0.761904761904762	0.412162162162162	122	290	43	0	0.963092171449284	1
"660"	"Biological oxidations"	174	174	13	0.0747126436781609	174	174	143	0.82183908045977	0.608108108108108	180	794	33	0	0.964185401796347	1
"863"	"Late Phase of HIV Life Cycle"	133	133	2	0.0150375939849624	133	133	108	0.81203007518797	0.641891891891892	190	659	55	0	0.968539739970937	1
"398"	"Presynaptic phase of homologous DNA pairing and strand exchange"	6	6	1	0.166666666666667	6	6	3	0.5	0.0641891891891892	19	19	12	0	0.968553258843874	1
"151"	"TCR signaling"	64	64	21	0.328125	64	64	50	0.78125	0.537162162162162	159	436	60	0	0.969521506604768	1
"153"	"Downstream TCR signaling"	46	46	15	0.326086956521739	46	46	35	0.760869565217391	0.439189189189189	130	262	60	0	0.971464083079903	1
"251"	"Translocation of ZAP-70 to Immunological synapse"	23	23	6	0.260869565217391	23	23	16	0.695652173913043	0.0945945945945946	28	76	7	0	0.978261793793992	1
"910"	"The citric acid (TCA) cycle and respiratory electron transport"	147	147	1	0.00680272108843537	147	147	119	0.80952380952381	0.675675675675676	200	809	59	0	0.979759519705695	1
"497"	"Adaptive Immune System"	654	654	82	0.125382262996942	654	654	552	0.844036697247706	0.861486486486487	255	3394	82	0	0.981150843708491	1
"785"	"HIV Life Cycle"	146	146	5	0.0342465753424658	146	146	118	0.808219178082192	0.665540540540541	197	722	55	0	0.98141553342213	1
"335"	"Assembly of the RAD51-ssDNA nucleoprotein complex"	5	5	1	0.2	5	5	2	0.4	0.0608108108108108	18	18	12	0	0.98262814060809	1
"259"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	51	51	13	0.254901960784314	51	51	38	0.745098039215686	0.432432432432432	128	274	24	0	0.989364515967706	1
"274"	"Phosphorylation of CD3 and TCR zeta chains"	25	25	6	0.24	25	25	17	0.68	0.114864864864865	34	87	14	0	0.9894810593156	1
"352"	"Xenobiotics"	20	20	4	0.2	20	20	13	0.65	0.097972972972973	29	97	19	0	0.990299972186698	1
"664"	"Chemokine receptors bind chemokines"	55	55	4	0.0727272727272727	55	55	41	0.745454545454545	0.199324324324324	59	149	16	0	0.99170744181985	1
"641"	"Disease"	1954	1954	162	0.082906857727738	1954	1954	1671	0.855168884339816	0.942567567567568	279	10305	82	0	0.992030009162985	1
"265"	"PD-1 signaling"	28	28	7	0.25	28	28	19	0.678571428571429	0.155405405405405	46	123	20	0	0.993437103244468	1
"774"	"Synthesis of PA"	28	28	1	0.0357142857142857	28	28	19	0.678571428571429	0.320945945945946	95	149	56	0	0.993437103244468	1
"452"	"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"453"	"Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"454"	"Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"455"	"Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"456"	"Defective CYP19A1 causes Aromatase excess syndrome (AEXS)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"457"	"Defective CYP1B1 causes Glaucoma"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"458"	"Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"459"	"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"460"	"Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"461"	"Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"462"	"Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"463"	"Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"464"	"Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"465"	"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"466"	"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"467"	"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"468"	"Defective FMO3 causes Trimethylaminuria (TMAU)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"469"	"Defective MAOA causes Brunner syndrome (BRUNS)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"470"	"Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"471"	"Phase 1 - Functionalization of compounds"	78	78	11	0.141025641025641	78	78	59	0.756410256410256	0.418918918918919	124	379	33	0	0.996080370153849	1
"732"	"Inflammasomes"	21	21	1	0.0476190476190476	21	21	13	0.619047619047619	0.226351351351351	67	86	13	0	0.996835470563254	1
"676"	"Translocation of GLUT4 to the plasma membrane"	60	60	4	0.0666666666666667	60	60	44	0.733333333333333	0.398648648648649	118	206	26	0	0.997001498023935	1
"379"	"Innate Immune System"	618	618	107	0.173139158576052	618	618	515	0.833333333333333	0.868243243243243	257	3899	85	0	0.99740744666572	1
"510"	"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"	8	8	1	0.125	8	8	3	0.375	0.0472972972972973	14	14	8	0	0.998602349862674	1
"482"	"Early Phase of HIV Life Cycle"	22	22	3	0.136363636363636	22	22	11	0.5	0.192567567567568	57	66	16	0	0.999972374410299	1
"351"	"Uptake and actions of bacterial toxins"	40	40	8	0.2	40	40	24	0.6	0.179054054054054	53	85	7	0	0.999984669143772	1
"391"	"Binding and entry of HIV virion"	12	12	2	0.166666666666667	12	12	3	0.25	0.0405405405405405	12	12	7	0	0.999998569563263	1
"212"	"Fc epsilon receptor (FCERI) signaling"	212	212	59	0.278301886792453	212	212	158	0.745283018867924	0.780405405405405	231	1209	82	0	0.999999641546016	1
"334"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	45	45	9	0.2	45	45	25	0.555555555555556	0.337837837837838	100	167	35	0	0.999999830502353	1
"311"	"Role of LAT2/NTAL/LAB on calcium mobilization"	141	141	30	0.212765957446809	141	141	97	0.687943262411348	0.699324324324324	207	856	82	0	0.999999992425914	1
"706"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	111	111	6	0.0540540540540541	111	111	69	0.621621621621622	0.27027027027027	80	265	14	0	0.999999999981872	1
"317"	"Fcgamma receptor (FCGR) dependent phagocytosis"	119	119	25	0.210084033613445	119	119	73	0.613445378151261	0.64527027027027	191	589	60	0	0.999999999999209	1
"435"	"Regulation of actin dynamics for phagocytic cup formation"	95	95	14	0.147368421052632	95	95	52	0.547368421052632	0.503378378378378	149	329	34	0	0.999999999999994	1
"174"	"FCERI mediated MAPK activation"	77	77	23	0.298701298701299	77	77	38	0.493506493506494	0.445945945945946	132	218	51	0	0.999999999999999	1
"299"	"FCGR activation"	50	50	11	0.22	50	50	11	0.22	0.189189189189189	56	75	17	0	1	1
"410"	"Role of phospholipids in phagocytosis"	62	62	10	0.161290322580645	62	62	22	0.354838709677419	0.364864864864865	108	247	60	0	1	1
"472"	"FCERI mediated NF-kB activation"	57	57	8	0.140350877192982	57	57	16	0.280701754385965	0.283783783783784	84	110	14	0	1	1
"549"	"Classical antibody-mediated complement activation"	44	44	5	0.113636363636364	44	44	3	0.0681818181818182	0.0405405405405405	12	20	7	0	1	1
"550"	"FCERI mediated Ca+2 mobilization"	62	62	7	0.112903225806452	62	62	25	0.403225806451613	0.25	74	99	17	0	1	1
"595"	"Creation of C4 and C2 activators"	50	50	5	0.1	50	50	8	0.16	0.236486486486486	70	93	55	0	1	1
"626"	"Initial triggering of complement"	57	57	5	0.087719298245614	57	57	15	0.263157894736842	0.25	74	121	55	0	1	1
"669"	"Complement cascade"	75	75	5	0.0666666666666667	75	75	32	0.426666666666667	0.317567567567568	94	227	55	0	1	1
"815"	"Binding and Uptake of Ligands by Scavenger Receptors"	76	76	2	0.0263157894736842	76	76	35	0.460526315789474	0.418918918918919	124	210	55	0	1	1
"844"	"Scavenging of heme from plasma"	47	47	1	0.0212765957446809	47	47	11	0.234042553191489	0.0777027027027027	23	32	6	0	1	1
